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T cell homeostasis describes the process through which the immune system
regulates cell survival, proliferation, differentiation and death to maintain T
cell numbers and diversity in a range of different conditions. The aim of this
thesis is to better understand how this process leads to the development of the
naive CD4+ T cell compartment during childhood. Mathematical modelling is
used in combination with experimental observations to estimate naive T cell
kinetics over the lifetime of an individual. The analysis described here shows
thatpost-thymicproliferationcontributesmorethandoublethenumberofcells
entering the pool each day from the thymus. This ratio is preserved from birth
to age 20 years; as the thymus involutes, the average time between naive T-cell
divisionsintheperipherylengthenswithageandthenaivepopulationismain-
tained by improved naive cell survival. Thymic output is quantiﬁed from birth
to age 60 years by combining models to interpret naive T cell TRECs and Ki67
expression data. Three distinct phases of thymic T cell output are identiﬁed: (i)
increasing production from birth to age 1 year; (ii) steep decline to age 8 years;
(iii) slow decline from age 8 years onwards. Finally, the role of inter-cellular
variation in T cell residency times is explored. It is able to explain the persis-
tence of PTK7+ naive CD4+ T cells in thymectomised individuals. Importantly,
the model predicts the accumulation of veteran PTK7+ T cells in older individ-
uals and suggests that the residual population in thymectomised individuals
will also consist predominantly of veteran PTK7+ T cells. The model has im-
plications for the use of PTK7 as a marker of recent thymic emigration and also
naturally explains improved T cell survival in older individuals.Publications & Abstracts
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T cell immunology: an
introduction
Tlymphocytesformanintegralpartoftheadaptiveimmunesystem. Theadap-
tive immune system allows the body to mount a response that is speciﬁc to
invading pathogen and confers long-term protection to re-infection with the
same antigen. Each T cell expresses a receptor on its surface that enables it to
recognise speciﬁc antigen-peptides in association with major histocompatibil-
ity (MHC) molecules. Together, the receptors on all lymphocytes cover a broad
repertoire of antigens.
1.1 T cell development
The role of the thymus as the primary source of peripheral T lymphocytes
was ﬁrst discovered by Jacques Miller through the study of neonatally thymec-
tomised mice [4]. Since then a huge body of work has further elucidated the
process through which T cell precursors are produced in the bone marrow, de-
velop in the thymus and enter the circulating pool as mature T cells. Thymic
development encompasses extensive differentiation, division, T cell receptor
(TCR) gene rearrangement and selection. Only a small fraction of thymocytes
survive the thymic process and go on to enter the peripheral circulating popu-
lation [5–7].1.1 T cell development 13
The thymus is largely comprised of the thymic epithelial space (TES), lym-
phocytic perivascular space and non-lymphatic thymic tissue including fatty
tissue, connective tissue and Hassall’s bodies. Thymopoiesis predominantly
occurs in the TES; the TES can be divided into the cortex and medulla and
 90% of thymocytes are found in the TES at any given time [8]. Early lym-
phocyte progenitors migrate through the subcapsular zone of the thymus be-
fore entering the cortex. Extensive proliferation takes place in the outer cortex;
the rearrangement of the TCR  chain is followed by division and maturation.
Thymocytes upregulate both CD4 and CD8 becoming double positive before
undergoing rearrangement of the TCR  chain. Following this, double-positve
TCR+CD4+CD8+ thymocytes migrate to the inner cortex where they un-
dergo extensive positive selection; cells that are able to recognise self-peptides
bound to major histocompatibility complex (MHC) ligands are saved from cell
death while those that fail to achieve a sufﬁcient threshold of TCR signalling
will be lost through death by neglect [9]. Death by neglect is thought to ac-
count for the loss of 80-90% of thymocytes. The ultimate CD4 and CD8 lin-
eage commitment of double-positive thymocytes is thought to depend on in-
teractions with self-peptide-MHC complexes on cortical thymic epithelial cells
(TECs) [10].
The chemokine receptor CCR7, expressed during positive selection, plays a
role in guiding the migration of single positive thymocytes to the medulla [11].
Thymocytes spend about half of their lifespan in the medulla before entering
the peripheral circulating lymphocyte population as mature naive T cells [12].
Negative selection is thought to predominantly occur in the medulla [13]; im-
mature thymocytes that demonstrate too high an afﬁnity to self peptide MHC
are lost to apoptosis. The mature T cell repertoire is ﬁnely tuned by the inter-
action between thymocytes and MHC complexes to allow for the recognition
of a diverse range of antigens while maintaining a high level of self tolerance;
Daniels et al. [14] found that, while the negative selection threshold is sharply
deﬁned, positiveselectionappearstooccuroverabroaderrangeofafﬁnities(as
illustrated in Figure 1.1). In the ﬁnal stages of thymic development thymocytes1.2 T cell function & activation 14
undergo a sequential change in the expression of several surface marker and
acquire the ability to functionally respond to a variety of stimuli [15–18].
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Figure 1.1: Afﬁnity model of thymic selection. The afﬁnity between the T cell
receptor and self-peptide MHC complex determines the outcome of positive and
negative selection and shapes the T cell repertoire (adapted from review by Klein
et al. [10])
1.2 T cell function & activation
The role of a T cell is to recognise foreign antigen expressed on antigen pre-
senting cells (APCs) in association with the MHC complex and initiate an ap-
propriate response. The initial interaction between a T cell and antigen-MHC
complex will typically occur in the secondary lymphoid organs. Each T cell
has a different antigen-binding speciﬁcity and the number of T cells that can
respond to a speciﬁc antigen is limited. As a result, the ﬁrst stage of T lympho-
cyte activation involves clonal expansion of the relevant T cell receptor clone.
Activated naive T cells undergo extensive proliferation and differentiation pro-
ducing effector and memory T cells. The lineage relationship between naive,
effector and memory T cells is not completely understood [19], however, it is
widely accepted that antigen speciﬁc T cell populations can expand up to 1000-
fold producing vast numbers of effector T cells that are able to destroy infected
cells and release cytokines that stimulate B cells. Following the clearance of1.2 T cell function & activation 15
infection, the majority of effector T cells are thought to be lost to apoptosis,
while a small fraction of antigen speciﬁc T cells will persist in the memory T
cell pool [20]. The intensity of this response and the size and function of mem-
ory cells induced will depend upon the strength of TCR activation, duration of
exposure to the MHC-peptide complex, the extent of binding, co-stimulation,
inﬂammatory factors, intrinsic expression of signalling proteins, possibly the
proximity of other cells and environmental stimuli.
Naive T Cell Activation
Following export from the thymus, naive T cells continuously circulate be-
tween the secondary lymphoid organs and peripheral blood [21,22]. One of
the key difﬁculties of studying human T cell dynamics is that only 2% of lym-
phocytes are found in the peripheral blood at any given time [23]; however,
studies have shown that nearly all lymphocytes will pass through the blood
each day [21] (Figure 1.2). Within the secondary lymphoid organs, APCs, such
as dendritic cells (DCs), macrophages or B lymphocytes, will present antigenic
peptides to naive T cells. It is thought that a naive T cell will sample the pep-
tides presented by APCs within a lymph node for several hours with the aim
of encountering its speciﬁc antigen. Despite the complex architecture of lymph
nodes, multi-photon microscopy studies reveal that naive T cells scan APCs
in the lymph nodes through random movements and at relatively high speed.
Each DC appears to interact with multiple T cells simultaneously, although, the
duration of each T cell-DC interaction is thought to be short-lived [24]. If a cell
fails to recognise its speciﬁc antigen it will return to the circulation through the
efferent lymph vessel; on average, a typical naive T cell is thought to spend
approximately half an hour in the circulation before homing to the next lymph
node [25]. The recirculation is thought to guided by chemokine receptors and
adhesion molecules such as CCR7, CXCR5 and CD31 [as reviewed by Andrian
et al. [26]].
Antigen-proteins are bound to MHC proteins on the surface of APCs and these
MHC-peptidecomplexesareabletobindantigenspeciﬁcTCR/CD3complexes1.2 T cell function & activation 16
on T cells to form immune synapses and induce TCR signalling in activated
naive T cells [27, 28]. The strength of T cell activation is regulated through
a combination of TCR afﬁnity, costimulation and inﬂammation. Naive CD4+
T cells require two signals to become activated; MHC binding with the TCR
and secondary interaction between costimulatory molecules, expressed on the
surface of activated APCs, and the CD28 coreceptor, expressed on the surface
of CD4+ T cells. Costimulation is thought to enhance proliferation, cytokine
production, cell survival, and the expression of CD40 ligands and adhesion
molecules necessary for trafﬁcking in response to antigen recognition [29]. Fol-
lowing successful activation by an immunogen naive T cells undergo clonal
expansion and differentiation to produce a population of antigen-speciﬁc ef-
fector T cells. Activation driven by lower-afﬁnity interactions with self-peptide
MHC (spMHC) lead to a homeostatic response that is discussed later in section
1.3.
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Figure 1.2: Schematic of T cell distribution and trafﬁcking between blood, sec-
ondary lymphoid organs and other tissues.1.2 T cell function & activation 17
Effector T Cells
Effector T cells represent a heterogeneous population with respect to their re-
sponse to differing invading pathogens. The lineage commitment of success-
fully activated T cells depends on the cytokine environment, transcription fac-
tors, antigen load and costimulatory molecules present during stimulation.
CD4+ effector T cells might differentiate into T -helper type 1 (Th1), type 2
(Th2), or type 17 (Th17) cells, deﬁned by their distinct cytokine secretion pro-
ﬁles, or they might evolve into regulatory T cells which suppress T cell acti-
vation and mediate self-tolerance. Effector CD4+ T cells lack CCR7 which is
required for lymph node homing and CD27 which is involved in T cell activa-
tion, and instead express a diverse range of homing molecules that allow them
to migrate to the site of the infection.
Th1 cells are thought to mediate cellular immunity against intracellular
pathogens including enhancing microbicidal activity by macrophages and cy-
totoxic cells [30,31]. Th1 cells are associated with high expression of interferon
gamma (IFN-) and interleukin-2 (IL-2) and are regulated by transcription fac-
tor T-bet. In contrast, Th2 cells are chieﬂy involved in mediating humoral im-
munity against helminths and other extracellular pathogens. They help B cells
to develop into antibody producing cells and recruit neutrophils, eosinophils,
and basophils to sites of infection and inﬂammation [30,31]. Th2 differentiation
is thought to be controlled by transcription factor GATA-3 and Th2 cells are
associated with expression and production of IL-4, IL-5, IL-9 and IL-13. Th17
cells are a population of CD4+ effector T cells characterised by their ability to
produce IL-17, IL-22 and IL-23. Their primary function is thought to involve
induction of tissue inﬂammation and immune responses against extracellular
bacteria and fungi. Human naive T cells are polarised towards the Th17 phe-
notype by TGF, which induces master transcription factor retinoid-related
orphan receptor (ROR)t, in combination with IL-6, IL-21 and IL-23 [32].
Effector T cell responses require strict regulation; excessive Th1 or Th17 re-
sponses can lead to organ-speciﬁc auto-immunity, whereas uncontrolled Th21.2 T cell function & activation 18
repsonses are thought to play a role in allergies and asthma [31]. Regula-
tory CD4+ T cells (Tregs) enable immune tolerance by suppressing effector re-
sponses [33]. Antigen presentation by DCs that express IL-10 is thought to
polarise activated T cells towards the formation of regulatory CD4+ T cells
(Tregs) [31]. Tregs are typically identiﬁed by expression of forkhead box P3
(FOXP3); the transcription factor that plays a key role in their differentiation
and function. Their immuno-suppressive function is dependent on signalling
via cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), a negative regu-
lator of T cell activation, as well as secretion of the immune-suppressive cy-
tokine, TGF (Read, 2000). In addition to Tregs that are induced from CD4+ T
cells in the periphery, primarily in gut-associated lymphoid tissue (GALT), the
Treg subset includes naturally occurring CD4+CD25+FOXP3+ Treg cells that
develop in the thymus.
The lineage commitment of CD4+ T cells was originally thought to result in sta-
ble terminally differentiated cells; once a naive cell had polarised towards Th1
or Th2 phenotype it was thought that this phenotype could not be reversed,
even when cells were exposed to conditions that promoted other effector lin-
eages [34]. However, recent work suggests that the local micro-environment,
through cytokine, cell-cell or cell-micro-organism contact, plays a role in direct-
ing and maintaining the lineage of effector T cells and it is not clear that such
a clear distinction exists between different effector T cell types [as reviewed
by Zhou et al. [31]]. T cells have been observed to co-express both Foxp3 and
RORt and it has been shown that Tregs have the ability to differentiate into
Th17 cells [35]. Similarly, there is evidence to suggest that Th17 cells can con-
vert to Th1 and Th2 cells in the presence of the appropriate cytokine induc-
ers [36]. Most recently, it has been shown that Th2 cells can be reprogrammed
to adopt an intermediate phenotype characterised by both Th1 and Th2 tran-
scription factors, GATA-3 and T-bet [37], suggesting a more complex picture of
T cell activation and differentiation than was previously assumed.1.2 T cell function & activation 19
Memory T Cell Activation
A unique feature of the adaptive immune system is the ability to remember
pathogens. Following infection, a small number of long-lived memory T cells
are produced. Memory T cells provide long-term immunity against recurring
antigens and can persist for decades; smallpox vaccination follow-up studies
suggest that T cell immunity declines with a half-life of  8-15 years and virus-
speciﬁc memory CD4+ and CD8+ T cells were detectable up to 75 years after a
single vaccination [38,39]. Memory T cells are able to mount a more effective
immune response than antigen-naive T cells; where effectiveness is measured
by magnitude, speed and sensitivity of response to antigen. One aspect of this
improved response follows from a higher frequency of antigen speciﬁc mem-
ory T cells; the naive T cell repertoire is more diverse than that of the memory
T cell population, but as a result the number of cells that are speciﬁc to a given
antigen will be smaller in the naive pool [40]. The memory response is typically
faster and results in more vigorous expansion, although, the differences in the
way in which naive and memory T cells respond to antigen encounter are not
fully understood.
Memory T cells can be divided into central memory T cells (TCM) and effec-
tor memory T cells (TEM) with distinct properties. TCM maintain the ability to
rapidlydivideinresponsetosecondaryantigenactivation, expressbothCD62L
and CCR7 and circulate between the blood and secondary lymph nodes. On
the other hand, it is thought that TEM do not undergo division in response to
secondary infection, do not express CD62L nor CCR7 and are thought to mi-
grate predominantly between the blood and peripheral tissues [41,42]. Further,
TEM demonstrate effector functions, such as cytolytic activity and cytokine se-
cretion, more rapidly than TCM on reactivation with antigen [43].
There are at least two different models for the way in which memory T cells
develop. A popular model is that activated naive T cells give rise to a large
number of effector T cells, the majority of which will be terminally differen-
tiated and die, while a small number will further differentiate into the mem-1.2 T cell function & activation 20
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T cells5,6. When does the lineage choice — 
either to become a terminally differentiated 
effector T cell and die or to progressively dif-
ferentiate into a memory T cell — occur and 
what are some of the molecular ‘deciders’?
S.L.R. As memory T cells are, of necessity, 
the progeny of antigen-experienced T cells, 
it was previously thought that memory 
T cells are derived from effector T cells, 
representing a second differentiation step 
for a select subset of those cells that are 
otherwise fated to die (linear differentiation  
model (FIG. 1)). This presumption was 
largely based on the idea that differentia-
tion is a unidirectional process — that 
T cells that are well differentiated are 
unlikely to revert to a less differentiated 
state — and was questioned by the initial 
description of central memory T (TCM) cells, 
which lacked full effector functions.
However, it is possible that the less differ-
entiated T cells might represent a divergent 
pathway of differentiation (bifurcative  
differentiation model (FIG. 1)).
Mechanistically, the observation that 
T cell fate may not be determined until 
after cell division led to the idea that one 
T cell could potentially have daughter cells 
with different differentiation fates. The 
possibility of intraclonal heterogeneity led 
to widespread interest in the early events 
that occur in the formation of gene expres-
sion patterns in activated T cells and their 
progeny. Research interests now focus on 
determining the nature and extent of this 
heterogeneity and diversification.
Douglas T. Fearon. The first question is 
whether a memory CD8+ T cell develops 
because it maintains a pre-existing ability 
to do so or because it acquires a new abil-
ity. Comparing the two extremes of CD8+ 
T cell development — that is, naive T cells 
in the lymph node and senescent terminally 
differentiated, antigen-experienced effector 
T cells in peripheral, non-lymphoid tissues 
— highlights three differences: replicative 
potential, tissue site and effector function. 
Only the first two differences are directly 
relevant to secondary clonal expansion,  
and therefore memory T cell ontogeny; 
effector function, although associated 
with the senescent terminally differentiated 
state of a cell, is not necessarily its cause. 
For example, both killer cell lectin-like 
receptor subfamily G, member 1 (KLRG1)– 
and KLRG1+ antigen-experienced CD8+ 
T cells have effector functions, but only the 
KLRG1+CD8+ T cells have lost the ability, 
that naive T cells have, to replicate (and are 
therefore senescent terminally differentiated 
effector T cells), because they can no longer 
induce the anti-senescent transcription 
factor BMI1 (REFS 2,7,8).
The second question is whether the 
conversion to senescent effector CD8+ 
T cells that reside in non-lymphoid tissues 
is irreversible. It has been suggested to be 
Figure 1 | Possible models of memory T cell differentiation. a | In the linear differentiation model, 
stimulation of naive T cells with antigen (in the presence of co-stimulatory signals and inflammatory 
cytokines) results in the generation of effector T cells. Effector T cells either become senescent termi-
nally differentiated T cells, which die by apoptosis soon after the pathogen is clear, or differentiate into 
effector memory T (TEM) cells that express low levels of CD62L (also known as L-selectin), do not express 
CC-chemokine receptor 7 (CCR7) or home to lymphoid tissues, and are replication incompetent. These 
cells can give rise to long-lived central memory T (TCM) cells that express CCR7 and CD62L, and 
undergo homeostatic proliferation in lymphoid tissues. b | The bifurcative differentiation model pro-
poses that following antigen recognition, one T cell can give rise to two daughter cells with different 
differentiation fates: the distal daughter cell gives rise to T CM cells and the proximal daughter cell gives 
rise to TEM cells and effector T cells, which undergo apoptosis following pathogen clearance. This type 
of differentiation could be achieved through asymmetric cell division or other mechanisms capable of 
generating heterogeneity. c | A third possible model (referred to here as the self-renewing effector 
model) suggests that a naive T cell can develop into a TCM cell or an effector T cell that can self-renew. 
These cells can home to lymphoid tissues and undergo homeostatic proliferation. It is proposed   
that these cells give rise to TEM cells that can migrate to sites of infection but do not self-renew. 
Senescent terminally differentiated effector T cells are proposed to derive from these TEM cells.   
APC, antigen presenting cell; TCR, T cell receptor.
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Figure 1.3: Possible models of T cell differentiation a: In the linear differentia-
tion model the effector phase is a necessary step in memory T cell formation by
activated T cells; b: The bifurcation model describes asymmetric division and dif-
ferentiation of one activated naive T cell into both memory and effector states; c:
The self-renewal model suggests that naive T cells differentiate directly into TCM;
TEM cells migrate to site of inﬂammation and become terminally differentiated ef-
fector T cells. Diagram from review by Ahmed et al. [19]1.3 Maintaining T cell numbers 21
ory T cell compartment and survive as long-lived memory T cells [40,44]. An
alternative to this linear T cell differentiation model is the idea that naive T
cells may undergo assymetric division upon antigen encounter, whereby one
daughter leads to the production of effector cells and the other controls the
production of a memory population. Evidence for this hypothesis comes from
imaging studies of activated T cells undergoing their ﬁrst division; Chang et
al. [45] showed that several proteins, including IFN-, are unequally divided
between the daughter cells leading to the production of either effector of mem-
ory T cells. Furthermore, studies of lymphopenia-induced proliferation have
shown that memory generation can occur in the absence of antigen stimula-
tion [46,47], suggesting that it may not be necessary for naive T cells to pass
through the effector phase in order to become memory T cells. The alternative
models are described in Figure 1.3.
1.3 Maintaining T cell numbers
The basic deﬁnition of homeostasis is the ability of an organism to maintain
equilibrium by adjusting its physiological processes. Evidence for homeostasis
and tight regulation of the T cell population came from early studies demon-
strating that the implantation of additonal thymi, or removal of the thymic
tissue, had a limited effect on the size of the peripheral T cell population [6,48].
Moreover, theabilityoftheTcellpopulationtoreconstitutefollowingimmuno-
depletion further supports the notion that T cell expansion and survival is gov-
erned by some awareness of available ”space” [49,50].
T cell homeostasis involves the regulation of cell division, differentiation, sur-
vival and death to maintain stable T cell numbers and diversity. It is inevitably
difﬁcult to observe T cell homeostatic processes in most situations since the
net effect of cell production and loss will be, by deﬁnition, negligible. A wide
array of experimental techniques are used to estimate the rate at which the T
cell population is turning over in vivo in healthy individuals, however, we still
do not have a clear picture of how the immune system is able to manipulate
thymic production, cell division and survival to maintain a functional T cell1.3 Maintaining T cell numbers 22
population over the lifetime of an individual. The disruption of T cell equilib-
rium by thymectomy, immuno-depletion and subsequent reconstitution allows
us to gain deeper insight into the underlying homeostatic processes.
Thymic output
The thymus is known to involute with age, however, it has proven difﬁcult to
quantify the number of cells that are exported each day and our knowledge
of the extent to which thymic production declines remains limited. Steinmann
& colleagues [8] conducted an extensive study of thymic tissue in individu-
als aged 0 to 107; although they observed no change in total thymic volume
with age, histological staining revealed an age-related decline in the relative
volume of the TES and a signiﬁcant increase in the proportion of adipose tis-
sue. This strongly suggests that thymic production diminishes with age since
the TES is thought to be the primary site for thymopoeisis and contains 90%
of thymocytes. Inference from histological studies is limited, however, by the
assumption that size necessarily correlates to function, or that the number of
cells reﬂects output.
More than a decade ago, T cell receptor excision circles (TRECs) were identiﬁed
as a surrogate marker of thymic output [51,52]. TRECs are excised DNA rem-
nants that are produced as a by-product of TCR gene rearrangement within
the thymus and are thought to be highly conserved within T cells. Douek et
al. [52] showed that TRECs were most prevalent in children but diminished
with increasing age, in accord with a decline in thymic output. TREC content
was also shown to be signiﬁcantly reduced in thymectomised and HIV-infected
subjects and correlated positively with naive T cell numbers. This work in-
spired a plethora of studies measuring TRECs to investigate the role of thymic
production in health and disease.
However, the same study by Douek et al. [52] showed that TREC concentration
was diluted by cellular proliferation since TRECs are not duplicated during
mitosis. As a result, the average TREC content per cell can be a misleading
measure of thymic function; a decline in TRECs is consistent with a decline in1.3 Maintaining T cell numbers 23
thymic output, however, it might also reﬂect an increase in peripheral division.
This was shown to be important by Hazenberg & colleagues [53] who reported
that a decline in TRECs in HIV infected individuals reﬂects increased prolifer-
ation rather than diminished thymic production. Later, mathematical studies
showed that the concentration of TRECs per ml, as opposed TRECs per cell,
would better reﬂect thymic output since the total number of TRECs does not
decline with division [54]. However, the use of TRECs to quantify thymic out-
put remains contentious since total TRECs reﬂect both thymic production and
the longevity of T cells; the contribution of T cell survival, which is likely to
vary with age and in immunodeﬁciency, remains an unknown.
CD31 (platelet endothelial cell adhesion molecule-1) is a cell surface marker
that is thought to identify two distinct subpopulations of naive CD4+ T cells
with unique properties and TREC content [55]. The per-cell TREC content
of CD31+ naive T cells is signiﬁcantly higher than CD31  naive CD4+ T cells
and since TREC content is diluted by peripheral expansion, CD31+ T cells are
thought to have spentless timein the periphery than theirCD31  counterparts.
CD31 is used as a surrogate marker for recent thymic emigration; studies have
shown that the fraction of CD31+ naive CD4+ T cells drops from  90% of all
CD4+ T cells at birth to 30% at age 60 years [55,56]. This compares to a 10-
fold drop in the number of TRECs per CD4+ T cell over the same period [52],
and a 15-fold decline in the relative size of the thymic cortex [8]. As with
TRECs, the size of the CD31+ naive CD4+ T cell population reﬂects a combi-
nation of thymic output, proliferation and cell loss through death or change of
phenotype. In order to accurately interpret the data quantitatively we require
an understanding of how naive cells divide and differentiate in-vivo and the ex-
tent to which cells may proliferate without losing the CD31 marker [56].
Peripheral turnover
In vivo isotope labelling studies are commonly used to study the turnover of
T cells in both healthy and HIV-infected individuals [57–62]. A stable, isotopi-
cally enriched precursor is administered to subjects and is then incorporated1.3 Maintaining T cell numbers 24
into the newly synthesised DNA of dividing cells. The number of labelled
cells is recorded over a series of timepoints during and post labelling and is
a measure of the cell division. Mathematical models are used to interpret the
labelling data and infer the underlying rates of T cell production and loss.
Deuterium labelling, both deuterated glucose and heavy water, works through
the administration of a non-radioactive, stable, isotopically enriched precur-
sor which labels the glucose in newly synthesised DNA. As opposed to BrdU,
deuterium is incorporated into DNA through the de-novo nucleotide synthesis
pathway. The enzymes of this pathway are up-regulated during S phase, hence
the efﬁciency of this pathway is thought to be high and constant in dividing
cells. It is also relatively unaffected by extracellular nucleoside concentrations.
BrdU is a pyrimidine nucleoside that is incorporated into DNA through the
nucleoside salvage pathway, as a thymidine analogue. This is not widely used
in humans because of toxicity. In addition, the efﬁciency of BrdU incorpora-
tion is unknown and depends on the availability of extracellular nucleosides.
BrdU labelling is also more complex to interpret since division leads to weaker
labelling and the decay of label is artiﬁcially accelerated by cells reaching a di-
vision threshold in addition to cell loss. The impact of this depends on how
many times a cell is likely to divide within the short labelling period. In con-
trast, during 2H glucose labelling only cell death results in loss of label.
Mohri and colleagues [59] originally noted that the rate of both CD4+ and
CD8+ T cell production as measured by deuterated glucose labelling in healthy
humans was considerably smaller than the rate of loss. Since the size of the
lymphocyte population was known to be approximately stable it was assumed
that the extra loss must be compensated for by the additional production of
unlabelled, or equivalently not recently divided, T cells from the thymus. An
alternative interpretation was later proposed by Asquith et al. [63] who iden-
tiﬁed that labelling studies measure the rate at which label is acquired by the
entire T cell population, whereas, the rate of loss is only measured in recently
divided T cells. It was argued that in a heterogeneous T cell population an
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the high rate of loss might only reﬂect loss from a small subset of rapidly divid-
ing but short-lived T cells that are disproportionately labelled and the average
rate of loss across the entire T cell population may equal the observed rate of
production.
Interestingly, further investigation of T cell subpopulations has revealed that
although the estimated rate of production exceeds the rate of loss in the mem-
ory CD4+ T cell compartment, the reverse is in fact true for naive T cells; re-
cently divided naive T cells appear to have a survival advantage over more
established naive T cells [62,64]. More recently, mathematical models that ex-
plicitly account for heterogeneous cell populations have been developed and
may provide further insight into the kinetic diversity that exists within the T
cell population [65]. Although it remains difﬁcult to determine the true rate of
T cell loss with in vivo labelling data, the method has allowed researchers to
estimate differential rates of production within different human T cell subsets;
CD4+ TEMare observed to have the highest average rate of division of 4.7% of
cells per day compared to 1.5% of CD4+ TCMper day, and a rate of only 0.2% of
naive CD4+ T cells per day [64].
An alternative approach to measuring cell division involves the use of cell cycle
antigen Ki67. Ki67 is expressed in late stage G1, S, G2 and M of cell cycle and
peripheral T cells can be stained, and counted, to quantify the proportion of
cells that are not at rest at any given time. The rate of division that is inferred
from Ki67 data is inversely correlated to the duration of Ki67 expression. A
length that is likely to be related to cell cycle time, a measure that has proved
surprisingly difﬁcult to estimate in-vivo. In vitro estimates for the inter-division
time of T cells range from  12 hours [66] to  19 hours in CD4+ T cells [67],
while in vivo studies of CD8+ T cells in mice suggest that the average division
time is closer to  8 hours [68]. In addition, there is some evidence to suggest
that cells may accumulate in the G1 phase of cell cycle in HIV-infected indi-
viduals, suggesting that in this scenario Ki67 may overstate the production of
cells through division [69]. Despite the difﬁculties associated with using Ki67
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pare rates of cell division in different cell populations in healthy individuals. In
accord with in vivo labelling studies,  0.5% of naive CD4+ T cells and 2% of
memory CD4+ T cells express Ki67 in healthy young adults [1]. Furthermore,
the proportion of dividing naive and memory CD4+ T cells is seen to decline
continuously from birth to  20 years but appears to be stable in adults until
the age of 70 years at which stage the rate of proliferation appears to almost
double [1,2,70].
Homeostatic mechanisms
In this section the mechanisms that drive T cell homeostasis and turnover
are discussed. T cell homeostasis has largely been studied in the context of
lymphopenia and often in TCR transgenic mice which means that interpreta-
tion of the results can be difﬁcult since T cell clones are often present at non-
physiological frequencies. Furthermore, the study of T cell homeostasis is con-
founded by the fact that in addition to variation in the signals that are available
to peripheral T cells, the ability of a T cell to respond to homeostatic cues may
change with its age and situation. Despite this, murine studies have enabled
the identiﬁcation of several key components of homeostasis.
Naive T cell homeostasis
There appear to be at least two independent mechanisms involved in naive
CD4+ T cell homeostasis; cytokine and self-peptide-MHC-TCR stimulation (as
reviewed by Surh & Sprent [71]). Foreign antigen-induced activation typi-
cally leads to a rapid expansion of speciﬁc naive T cells and the production
of a large number of effector cells, a small fraction of which will survive and
attain memory phenotype. The role that this process plays in the long-term
development of the naive T cell population is not well understood, although,
it is generally thought not to have a major inﬂuence on naive T cell home-
ostasis since antigen-activated cells rapidly differentiate away from the naive
phenotype. However, a number of studies have shown that TCR interactions
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eral naive CD4+ T cells [72,73]. It is not known whether cells undergoing self-
peptide MHC-induced homeostatic proliferation rely on distinct signals to cells
undergoing antigen-MHC-induced proliferation. T cells undergoing homeo-
static proliferation have been shown to express a subset of genes turned up
by full antigenic stimulation, including those involved in cell cycle but exclud-
ing those associated with effector activity, however, the degree of induction
appears to be signiﬁcantly lower, suggesting that the intensity of the T cell re-
sponse is dependent on the level of stimulation [74]. Mathematical modelling
of lymphopenia-induced division in response to self-peptide MHC stimulation
suggests that it is best described by a process whereby cells undergo indepen-
dent, single, stochastic divisions, as opposed to a pre-programmed sequence of
divisionsthatisthoughttobeinducedinresponsetoantigenicstimulation[68].
Furthermore, studies suggest that TCR-driven survival and proliferation are
induced through two distinct pathways [75].
In addition to TCR-mediated signalling, it is well established that naive T cell
homeostasis relies on cytokine signalling; removal of the c chain through
which many common cytokines signal (including IL-2, IL-4, IL-7, IL-9, IL-15
and IL-21) results in the loss of the peripheral naive T cell population [76,77]. In
particular, IL-7 is thought to play an essential role in proliferation and survival;
in the absence of IL-7, naive T cells fail to divide and are short-lived [78–81].
Moreover, it has been shown that the basal levels of free IL-7 controls the size
of the naive T cell pool [79]. The T cell response to IL-7 is thought to be tightly
modulated by the IL-7R chain (CD127) that dimerises with the c chain to
form the IL-7 receptor [82,83]. IL-7R has been shown to be down-regulated
in activated T cells [78]. Naive T cells have also been found to downregulate
CD127 after contact with IL-7 but upregulate CD127 in the absence of IL-7 [84],
suggesting a feedback mechanism through which T cells are able to respond to
the concentration of IL-7 availability.
Murine studies have shown that both lck-mediated TCR and IL-7R signalling
can induce naive T cell division in lymphopenic hosts [75,85], however, the rel-
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for speciﬁc T cell clones and depend on the severity of lymphopenia. The role
ofIL-7mayalsovarywithage; naiveCD4+ Tcellsderivedfromcordblood, but
not adult naive CD4+ T cells, are able to proliferate in response to IL-7 stimu-
lation in the absence of TCR activation [86]. More recently, the same difference
was observed between adult and neonatal murine recent thymic emigrants and
stimulation was associated with faster down-regulation of IL-7R in neonatal
T cells [87].
Memory T cell homestasis
It is generally agreed that memory T cells are derived from naive T cells, how-
ever, the transition from naive to memory is not fully understood and is a long
way from being quantiﬁed. The size of the memory pool remains fairly ﬁxed
in adults despite continuous antigen-induced expansion and the creation of
new memory cells suggesting that some form of replacement takes place. A
common paradigm has been that the expansion of a particular T cell clone will
inevitably lead to the shrinking of other memory T cell clones and sequen-
tial heterologous viral infections have been observed to cause severe attrition
of pre-existing lymphocytic choriomeningitis virus (LCMV)-epitope-speciﬁc
CD8+ memory T cells [88]. However a recent study showed that, although
the size of the CD8+ TCM population is tightly regulated, the TEM pool appears
to be able to expand following repeated immunization [89]. Moreover stud-
ies of human cytomagalovirus infection did not detect any quantitative impact
of infection upon numbers of blood-born inﬂuenza- and EBV-speciﬁc CD8+
memory T cells [90], suggesting a complex relationship between the survival
prospects of an individual T cell clone and the stability of the memory T cell
pool as a whole.
In addition to the acquisition of new cells through differentiation, the memory
T cell population is maintained by homeostatic proliferation; memory T cells
are observed to divide more vigorously than naive T cells in both healthy chil-
dren and adults [61]. Furthermore, in-vivo isotope labelling studies show that
the CD4+ TEM pool is turning over at a higher rate than the TCM pool [64]. In-1.3 Maintaining T cell numbers 29
terestingly, transfer of CFSE-labelled cells and BrdU labelling revealed that the
reverse is true of CD8+ T cells; TCM cell homeostatic division was observed to
outstrip TEM cell division in the CD8+ pool [44].
Homeostatic proliferation of both CD4+ and CD8+ memory T cells is thought
to require IL-7 and IL-15 [76,91, 92]. Unlike naive T cell homeostasis, mem-
ory T cell survival and turnover appears to be largely independent of MHC-
interactions in both CD4+ and CD8+ memory T cells [93–95]. CD8+ T cells
are able to sustain homeostatic renewal and function in the absence of MHC
I [94] and although ablation of TCR signalling capacity in mature CD4+ T
cells results in impaired function and turnover, population size remains con-
stant [96–98].
In order to maintain a stable memory T cell population, the addition of new
cells through proliferation and differentiation must be countered by cell death.
Mathematical modelling has been used to show that Fas-mediated apoptosis
within the proliferating compartment can explain density-dependent survival
of memory T cells in the absence of competition for resources [99]. The balance
of anti-apoptotic (Bcl-2) to pro-apoptotic Bcl-2 family members appears to be
another way in which T cell death is regulated. It has been shown that Bcl-2, a
factor that blocks the induction of activation-induced cell death (AICD), is up-
regulated following TCR-mediated activation. BIM (Bcl-2 interacting mediator
of cell death) is an example of a pro-apoptotic factor that is simultaneously up-
regulated following TCR triggering and cytokine deprivation. BIM is thought
to induce cell death by binding Bcl-2 and abrogating the inhibition of cell death
by Bcl-2 [As reviewed by Krammer et al. [100]]. Interestingly, CD8+ TEM cells
were associated with reduced resistance to AICD and decreased expression of
anti-apoptotic factor Bcl-2 than TCM cells [101]. It appears as though the regula-
tion of T cell death is ﬁnely tuned by the balance of complex molecular interac-
tions that decide whether a cell lives or dies according to different conditions
that may differ in different cells.1.4 Age associated changes 30
1.4 Age associated changes
In line with the normal physiological development of other organs and tis-
sues, the immune system grows until adulthood and then maintains a rela-
tively consistent size until old age. Studies have shown that the concentration
of CD4+ T cells (measured per microlitre of blood) decline exponentially with
age from birth to adolescence [102,103]; however, when allowances are made
for the growth of blood volume with age, it can been shown that healthy chil-
dren undergo an age-related increase in both total body naive and memory
CD4+ T cells [2]. At birth, the naive compartment constitutes over 90% of both
CD4+ and CD8+ T cells [102,103]. Aging coincides with a relative decline in
naive T cell numbers; the ratio of naive to memory T cells approaches approx-
imately 1:1 by age 20 years. This reﬂects the fact that the memory CD4+ T
cell population outgrows the naive CD4+ T cell population from birth to early
adulthood [2,103]. Both the naive and memory T cell compartments remains
relatively stable from age 20 years to old age [70,102–104].
The T cell response is highly dependent on the ability of a T cell to recognise
antigen peptides through the T cell receptor and the immense receptor diver-
sity of the naive T cell population allows the immune system to respond to new
antigens. Naive T cells express  107 different TCR -chains, each of which
is paired with 100 different -chains, resulting in  109 distinct T cell recep-
tors [105,106]. In contrast, the receptor diversity of the memory T cell compart-
ment is more contracted and consists of  105-106 different TCR -chains, each
paired with one or two different -chains.
PCR/oligonucleotide hybridization studies have shown that the average fre-
quency of TCR sequences (speciﬁc clones) within the naive CD4+ T cell pop-
ulation are fairly constant between the ages of 20 and 65 years, however, the
frequency of speciﬁc clones was found to be signiﬁcantly higher in subjects
aged 75-80 years [70]. This suggests that TCR diversity is well maintained in
adults to age 65 years despite a decline in thymic production of new naive T
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T cell compartment, although the repertoire of TCR--chains in the memory T
cell compartment was shown to be 10-fold less than that in the naive T cell
compartment. In agreement with this, CDR3-V spectratyping has been used
to demonstrate the relative preservation of clonality in both CD31+ and CD31 
naive T cell subsets to age 60 years [56].
Thymectomy as a model for premature aging
Thymectomy is tolerated without clinical consequences in humans as young as
6 months old [107], whereas, early neonatal thymectomy in mice is known to
inhibit the development of the peripheral T cell population [4]. Thymectomy is
typically characterised by an initial drop in both CD4+ and CD8+ T cell num-
bers and TRECs [108–111]. Integral to the post-thymectomy dynamics is the
fall in the size of the naive T cell compartment, while memory T cell number
have actually been observed to increase [112–114].
Long-term studies in young adults who were thymectomised during early
childhood reveal persistently low CD4+ and CD8+ T cell counts and smaller
naive T cell compartments than healthy controls [113,114]. However, thymec-
tomised subjects are able to maintain a reasonable number of T cells and one
explanationforthisistheobservedincreaseinperipheraldivision, asmeasured
by Ki67 expression, among CD4+ naive T cells [114]. Interestingly, almost two
decades after thymectomy 50% of naive CD4+ T cells remained CD31+ com-
pared to 70% in healthy age-matched controls [113].
Despite their young age and lack of clinical symptoms, long-term follow-up
studies have shown that the distribution of T cell subpopulations in thymec-
tomised subjects resembles that of older individuals [114], suggesting that
thymectomy may prove to be a useful model of premature aging. In support
of this, a recent vaccine study reported that thymectomised children produced
delayed antibody responses to tick-borne encephalitis vaccination that is more
typical of elderly individuals [115], although, previous studies have shown no
signiﬁcant difference in antibody production to tetanus toxoid, measles and
mumps [109,116].1.5 Mathematical Modelling in Immunology 32
1.5 Mathematical Modelling in Immunology
Modelling in general can be used to both predict and explain the behaviour of
the immune system. Most models will seek to simplify complex interactions
between different components of the immune system in order to capture key
relationships between different variables. For example, it would be almost im-
possible to model the behaviour of each individual T cell trafﬁcking between
the lymph nodes, spleen and blood. Instead, models of T cell population dy-
namics most often ignore spatial variations in T cell behaviour within a host
in order to describe more general rates of cell production and loss across the
entire T cell pool. Mathematics provides a language for expressing such mod-
els and a framework for analysing the consequences of the relationships and
assumptions that are deﬁned by the modeller.
Ordinary differential equation models
Ordinary differential equation (ODE) models are one of the simplest tools
used in mathematical modelling. An equation is used to relate the value of
a variable, in this case T cell population size, and its derivatives, which in the
straightforward ﬁrst order case will be the rate at which T cell numbers change
with time. While only a small subset of ODEs can be solved analytically, com-
putational/numerical methods allow solutions to be determined to a high de-
gree of accuracy in most cases. The are many examples where ODEs are used
in immunology.
One important use is in the quantitative interpretation of data from in vivo
DNA labelling studies [58,59,61]. Typical models assume that T cells divide at
some constant rate, , and that labelled, or equivalently recently-divided cells,
are lost at some constant rate, d, over the labelling and de-labelling period. This
is modelled by a system of ﬁrst order differential equations. The model is used
to estimate the rate of division and death of T lymphocytes that best describes
the experimental observations.
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asites and diseases such as HIV [117,118]. Perelson et al. [117] modelled the
behaviour of uninfected T cells, infected T cells and free virus in HIV infection
to great effect and were able to quantify the half-life of plasma virions as well
as explaining the dynamics of early phase infection. The longer asymptomatic
phase of HIV infection has been more difﬁcult to explain. An ODE model was
used by Yates et al. [119] to show that the chronic activation hypothesis, as it
stands, in which elevated proliferation drives further virus production, can not
explain the observed slow decline in CD4+ T cell numbers.
Stochastic models
A deterministic model is one in which a given starting point will always lead
to the same outcome for a given set of parameters, such as rates of production
and loss. In contrast, a stochastic model allows for some randomness within
the parameters. For example, instead of a ﬁxed value for the rate of division,
, the rate might be deﬁned by a probability distribution, say a normal dis-
tribution with mean  and standard deviation . As a result, each model
simulation will use a slightly different rate of division, chosen randomly from
the distribution, and give a slightly different outcome.
In theoretical immunology, stochastic models are commonly used to interpret
cell division data from carboxyﬂuorescein diacetate succinimidyl ester (CFSE)
labelling studies [66, 120–123]. CFSE ﬂuorescence decreases approximately
two-fold upon division and allows the division history of labelled cells to be
tracked over time. The process of entering cell division or dying is thought to
have a strong stochastic element which makes it ideally suited to be described
by a probability distribution rather than a single rate. Studies have shown that
the variation in time to ﬁrst division by resting lymphocytes, in vitro at least,
broadly conforms to a lognormal distribution [120]. Branching processes pro-
vide a useful way of modelling the random variation that exists at a single cell
level as well as the changes that occur between division classes; in a typical
model, the probability of undergoing the nth division is drawn from the same
distribution for all cells that have divided n   1 times.1.5 Mathematical Modelling in Immunology 34
Optimisation algorithms are used to identify the underlying parameters and
standard probability distributions that best describe the observed CFSE data.
This approach allows for the estimation of time to division, cell cycle time,
and average death rate. However, a key limitation of this approach is that it
is not always possible to identify a unique solution for underlying parameters
of lymphocyte loss and division, particularly if the probability of division or
loss changes with division number. An alternative approach has been to use
mathematical modelling to differentiate between different models of cell divi-
sion [68]. In this case a likelihood-method is used to identify the most feasible
from two or more distinct theoretical models of cell division and loss.
Age structured models
Age structured models allow individuals, or lymphocytes, to be tracked ac-
cording to their age and can provide deeper insight into the population dy-
namics. In this type of model, cells enter the youngest age class and then ei-
ther progress naturally into an older class or die with some probability (which
might be deﬁned by a deterministic rate or a probability distribution). Age
structured models allow the modeller to explore how the composition of the
population might change with time, in addition to broader changes to total
numbers. Models of this type are commonly applied in epidemiology to ac-
count for increased susceptibility to infection in elderly or very young individ-
uals but can also be applied at a cellular level if there exists variation in the
dynamic or functional properties of cells according to their age.
Spatial models
The development of spatial models of T cell dynamics have been enabled by
advances in two-photon microscopy [24]. The imaging of T cell migration
through intact lymph nodes, in combination with mathematical analysis, has
led to the construction of spatially explicit models of DC and T cell migration
patterns [124]. These models allow the rate at which T cells scan the lymph
node environment to be estimated and provide insight into whether T cell mi-1.6 Aims of this thesis 35
gration is random or guided.
Monte Carlo methods
Monte Carlo methods provide a powerful tool for solving mathematical prob-
lems that might otherwise be unfeasible analytically. The principle behind the
Monte Carlo approach is to identify the probability distribution of some vari-
able by repeating an experiment (simulation) to obtain observed values of the
variable. If the simulations are repeated a sufﬁcient number of times, it is as-
sumed that the distribution of observed values will converge to the actual dis-
tribution. The method can be used to estimate the uncertainty (or variation)
associated with some new variable that is a complex function of observable
variables, such as age and weight, where the probability distribution for these
variables is known.
The strength of the approach lies in its application to the solving of inverse
problems and parameter estimation. The basic idea is to move randomly
through the feasible parameter space and consider the probability of observ-
ing the experimental data for each parameter value that is chosen. The al-
gorithm, known as the Metropolis algorithm [125], is more efﬁcient than tra-
ditional methods since each sampled parameter value is accepted or rejected
according to its likelihood.
1.6 Aims of this thesis
Aging is thought to be associated with a continuous decline in thymic pro-
duction of mature naive T cells [8], although, the exact rate of involution and
quantity of thymic output remain unknown. Naive T cells are thought to be
relatively long-lived and relatively quiescent, however, human in vivo labelling
studies suggest that low-level division and replacement occur continuously
within the peripheral population. At the same time Ki67 expression suggests
thatthere isa decline inthe rateofperipheral expansionwithage. Theunderly-
ing mechanisms that allow the immune system to adapt to a decline in thymic1.6 Aims of this thesis 36
production while maintaining T cell diversity and numbers are not well under-
stood.
The aim of this thesis is to better understand the role of T cell homeostasis
in the development and maintenance of the naive CD4+ T cell compartment in
humans. Thecontributionofthymicproduction, peripheralexpansionandsur-
vival to the development of the naive CD4+ T cell population during childhood
is investigated. The ability of the naive T cell population to persist following
complete thymectomy is a testament to the effectiveness of T cell homeosta-
sis. Mathematical modelling and experimental data are combined to explore
the kinetics of the naive CD4+ T cell compartment in normal aging and fol-
lowing thymectomy. The objective is to identify rules that determine T cell
behaviour and might allow us to better understand the processes that drive T
cell turnover and allow for the growth and maintenance of an effective naive T
cell pool.Chapter 2
Quantifying the development of the
mature naive CD4+ T cell pool in
humansAbstract
What are the rules that govern a naive T cell’s prospects for survival or di-
vision following export from the thymus into the periphery? In this chapter
experimental data is combined with robust mathematical models to estimate
the absolute contributions of thymic export, division and loss to the popula-
tion dynamics of the human naive CD4+ T cell pools between the ages of 0
and 20 years. Despite the observed decline in the frequency of these cells in
blood with age, total body numbers of naive CD4 T cells are found to increase
throughout childhood and early adulthood. Post-thymic proliferation makes a
2-fold larger daily contribution to total numbers than thymic export, and the
relative contribution of thymic export and peripheral expansion appears to be
constant until age 20 years. Our analysis suggests that as thymic export de-
clines with age, healthy naive CD4 T cell turnover becomes progressively less
dynamic; the average time between cell divisions lengthens and cell survival
times increase. Together with other studies, our results suggest a complex pic-
ture of naive T cell homeostasis in which population size, time since export
from the thymus or time since the last division can inﬂuence a cell’s prospects
for survival or further divisions.2.1 Introduction 39
2.1 Introduction
An adult human has a population of roughly 1011 naive CD4+ T cells circulat-
ing in their peripheral lymphoid organs and blood. From early in development
this population is generated and sustained by thymic export and division in
the periphery, and is estimated to comprise at least 108 different T cell recep-
tor speciﬁcities [105] providing a broad spectrum of protection in a diverse
pathogen environment.
The rate of export of naive T cells from the thymus declines substantially with
age in healthy individuals [8], but estimates of the total number of cells ex-
ported from the thymus over an individual’s lifetime are still approximately
10-fold greater than the total number of naive T cells in an adult at any one
time1. Further, at least a subset of naive cells continues to divide slowly after
release from the thymus into the periphery. These two observations imply that
turnover and replacement occurs in the naive T cell pool. What are the rules
that govern a circulating naive cell’s prospects for survival and proliferation?
Do these rules change as we age, and if so, how? Identifying these rules is es-
sential for understanding the dynamics of the T cell pool when dysregulated
– for example, during the reconstitution of the T cell pools after medical inter-
ventions that induce lymphopenia, or following antiretroviral therapy in HIV
infection. Addressing these questions requires a combination of experimental
approaches and mathematical models.
As a ﬁrst step, here the relative contributions of proliferation, loss and thymic
input to the development of the healthy naive T cell compartment is quanti-
ﬁed. The youngest age groups might be expected to have the most dynamic T
cell populations, because rates of thymic export are highest and physiological
growth, in particular, growth of blood volume and lymphoid tissue, is con-
tinually altering the environment in which the T cells circulate and encounter
homeostatic signals.
1The estimate of daily thymic output by [8] in equation (2.3) integrated over 80 years gives
5  1012 cells.2.1 Introduction 40
Currently the most direct methods for measuring lymphocyte dynamics in vivo
employ deuterated glucose or heavy water to label dividing cells. Interpreta-
tion of some of the data from these studies is controversial, however, and for
ethical reasons the approach is difﬁcult to use in children. Much of our under-
standing of the population dynamics of the human naive T cell pool from early
in development to young adulthood has been gained through more indirect
methods and through extrapolation from mouse studies. Most commonly, the
contribution of thymic export has been assessed using the frequency of T cells
in blood expressing markers of recent exit from the thymus and the T cell re-
ceptor excision circle (TREC) content of naive cells. TRECs are circular nuclear
DNA fragments that are stable remnants of the recombination events that gen-
erate T cell receptor diversity in the thymus, and are shared randomly between
daughter cells upon division. The mean per-cell TREC content of the naive T
cell pool is a poor measure of thymic function, however, since TRECs are di-
luted by division in the periphery. This is particularly problematic when trying
to compare thymic function across different levels of lymphopenia, since rates
of peripheral division may vary substantially. In contrast, total TREC num-
bers are not affected by peripheral division. Measurement of total TRECs in
the naive pool, rather than TREC frequency, thus provides (somewhat noisy)
information regarding the balance between thymic export and the removal of
naive cells through loss, cell death or differentiation [54].
Naive CD4+ T cells are maintained homeostatically in the periphery by com-
petition for cytokines and possibly self-peptide/MHC signals [92]. Average
rates of division and/or loss are then expected to depend on the total number
or density of cells competing for these resources. Evidence for such competi-
tion or resource-limitation comes from studies in which lymphopenia and the
availability of survival or proliferative stimuli are manipulated in mice, result-
ing in changes in the survival times and rates of homeostatic proliferation of
naive T cells [68,79]. Previous approaches to modeling homeostasis of replete T
cell pools have represented the notion of competition or quorum-sensing with
heuristic forms for the average rates of proliferation and loss as functions of2.2 Mathematical model 41
total population size [2, 99, 126, 127]. However, the predictions and insights
gained from these models may then be contingent on the speciﬁc forms of these
functions.
In this work, data from a number of existing human studies is combined with a
simple and quite general mathematical model of naive T cell population dy-
namics. This approach allows us to estimate the absolute contributions of
thymic export, proliferation and loss to total body naive CD4+ T cell num-
bers, and how these contributions change over time between birth and young
adulthood. Importantly, this model makes no assumptions regarding the den-
sity dependence of proliferation and loss of naive cells in the periphery, and
so provides robust estimates of the age-dependent rates of these fundamental
processes in humans.
2.2 Mathematical model
Estimating total body naive CD4+ T cell numbers
In order to measure the contributions of division and loss to the naive pool, es-
timates of total naive cell numbers as a function of age are required. Peripheral
naive T cell levels are typically quoted in units of cells per ml or l of blood,
and these values decline with age [102, 103]. However, as noted previously
by Hazenberg et al. [2], the additional information of blood volume, which in-
creases during early life, is needed to estimate total body naive T cell numbers.
Further, naive T cells circulate continuously between blood and lymphoid or-
gans and approximately 2% are found in the blood at any moment [23]. In what
follows, then, total body naive T cell numbers is estimated by multiplying the
cells per unit volume of blood by 50  total blood volume.
To our knowledge, there are no published studies directly specifying the de-
pendence of mean blood volume on age. Instead published estimates of the
dependence of blood volume on body weight (Figure 2.1B), and of mean body
weight on age are used (Figure 2.1A). These are brought together with an2.2 Mathematical model 42
estimate of the age-dependence of naive cell density per microlitre of blood
in healthy children (Figure 2.1C) to give a non-linear function for mean total
body naive cell numbers as a function of age (Figure 2.1D). A Monte Carlo ap-
proach is used to combine the uncertainties in these regression estimates and
the population-level variations in physiology to estimate the distribution of
total naive T cell pool sizes across individuals of a given age. Details of this
procedure can be found in Appendix 2.5.1.
There is some evidence that the proportion of cells in blood itself may be age-
dependent; in Appendix 2.5.2 it is shown that this has only a minor effect on
our conclusions.
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Figure 2.1: A: Body weight as a function of age (from Kuczmarski et al. [128]).
B: Blood volume as a function of age, estimated from panel A and the regression
relation between weight and blood volume in Linderkamp et al. [129]. C: Mean
naive CD4+ T cell density in blood with age, using the relation in Huenecke et
al. [103]. D: Estimated total body naive CD4+ T cell numbers, using the data in
panels B and C. Panels A, B, C and D show the mean and estimated 95 percentiles
at the population level.2.2 Mathematical model 43
EstimatingthedistributionoftotalbodynaiveTcellTRECs
Douek & colleagues [1] measured the frequencies of TCR rearrangement exci-
sion circles in naive CD4+ T cells (as TRECs per g of DNA) in healthy individ-
uals aged 0 to 80. Using their data for individuals aged 0 to 20 years only, no
signiﬁcant change in the TREC content of naive CD4+ T cells was found with
age, although there was considerable variation between individuals (Table 2.1;
Figure 2.2A; p=0.11). Stability of TRECs during childhood is also observed in
other studies of naive CD4+ T cells by Douek et al. [52], naive CD8+ T cells
by McFarland et al. [130], and PBMCs by Zhang et al. [131]. Assuming that
1 g of DNA represents 150,000 cells, the mean TREC number () per naive
CD4+ T cell in this age range is estimated to be 0.084 (0:01 s.e.m.), and the
values of  among the pooled individuals were well described by a lognormal
distribution with parameters, =-2.4 and =0.46. Again using a Monte Carlo
approach, this distribution is combined with our empirical distribution of to-
tal naive T cell numbers to to generate an empirical distribution for total body
TRECs (= N(t)) across the population as a function of age (Figure 2.2B).
Subject ID Age (years) TRECs per Naive CD4+ T cell
A1 0 0.096
A2 0 0.166
A3 0 0.091
A4 0 0.090
A5 6 0.066
A6 7 0.067
A7 8 0.035
A8 9 0.068
A9 10 0.106
A10 12 0.074
A11 13 0.123
A12 15 0.066
A13 17 0.036
Table 2.1: Observed frequency of TRECs per naive CD4+ T cell in healthy individ-
uals age 0 to 20 years. Data from Douek et al. [1]2.2 Mathematical model 44
 
 
   
   
 
 
 
 
 
 
 
0 5 10 15 20
0
0.05
0.1
0.15
0.2
0.25
Age  years 
T
R
E
C
s
p
e
r
n
a
i
v
e
T
c
e
l
l
0 5 10 15 20
0
1 x1010
2 x1010
3 x1010
Age  years 
W
h
o
l
e
b
o
d
y
T
R
E
C
s
A  B 
Figure 2.2: A: Measurements of TRECs per naive CD4+ T cells, taken from [1]. B
Estimated distribution of total TRECs in the naive CD4+ T cell pool.
Naive CD4+ T cell and TREC dynamics
A very general population model is used to explore the dynamics of naive T
cells with an input term from thymic export, a term for population growth
(division in the periphery that preserves naive phenotype) and one for cell loss.
As above, we let N(t) be the total number of naive CD4+ T cells in the body at
age t, measured in days. Changes in this population with age t are described
using a generalised version of a standard model of naive cell dynamics used
by several authors [53,54,126]:
dN(t)
dt
= (t) + (t)N(t)   (t)N(t); (2.1)
where (t) is the rate of export of cells from the thymus (cells day 1), (t) is
the per-cell rate of addition to the naive pool through successful cell division
(day 1), and (t) is the per-cell rate of disappearance of cells from the naive
pool (day 1). The latter is a composite of cell death, change of phenotype and
loss. From here on these processes are collectively referred to as ’loss’.
In differential equation models of this sort, the per-cell ’rate’ of a process is a
measure of the probability any given cell will undergo that process in a short
time interval. The quantity 1=(t) can be interpreted as approximately the ex-
pected time to the next successful division of a naive cell in an individual of
age t, and 1=(t) is approximately the expected residence time of a CD4+ T cell
in the naive pool in an individual of age t.2.2 Mathematical model 45
The mean rates of division and loss in the periphery are allowed to change
with age, but in this model we do not impose functional forms for this age-
dependence nor do we assume any particular dependence of these rates on
the pool size N(t). Note also that naive T cells of different speciﬁcities and
recent thymic emigrant/mature naive cell status are treated as a homogeneous
population; here it is the mean rates of division and loss across the whole naive
CD4+ T cell compartment that are of interest.
We let the total TRECs in the naive CD4+ T cell pool at age t be T(t). T is
only inﬂuenced by thymic export and loss, but not division. The model ﬁrst
described by Hazenberg et al. [53] is used to describe TREC dynamics in the
naive population:
dT(t)
dt
= c(t)   (t)T(t); (2.2)
where c is the mean TREC content of cells emerging from the thymus, and
(t) and (t) are deﬁned above. It is assumed that intracellular degradation
of TRECs over time is neglible, and that the average TREC concentration of
CD4+ T cells emerging from the thymus, c, is constant up to age 20 years [132].
Junge et al. [133] reported an average 250 TRECs per 1000 recent thymic em-
igrant (CD31+) CD4+ T cells at birth, giving an estimated lower bound of
c = 0:25. Okamoto et al. [134] measured the TREC content of single-positive
CD4+ thymocytes in neonates to be  0.6; this provides a conservative upper
bound for c since cells are expected to undergo division between acquisition of
single-positive status and exit from the thymus. In what follows, let estimate
c=0.25.
Modeling thymic export
Thymic function is assumed to be proportional to the volume of the thymic
epithelial space (TES). Steinmann et al. [8] showed that the involution of the
TES with age could be described well by a modiﬁed exponential decay func-
tion. There remains an unknown constant of proportionality that relates the
the volume of the TES to the rate of naive CD4+ T cell export from the thymus
in cells/day. The proportionality constant is estimated by scaling the Steinman2.3 Results 46
decay function to obtain a daily thymic export rate of 108 cells per day at age
30, in accord with previous studies [126,135]. This is a combined predicted out-
put of both CD4 and CD8 T cells. Jamieson et al. [132] showed that the ratio of
CD4 to CD8 single positive mature thymocytes in fetal and adult thymi were
similar, and the average CD4 proportion was observed to be 0.68. This gives
an estimated thymic output of 6:8  107 naive CD4+ T cells per day at age 30.
This is used to calibrate the thymic export function and derive the following
estimate for the mean rate of thymic export as a function of age t:
(t) = 2:32  10
8 exp( 1:1  10
 4t) + 1:15  10
8 exp( 1:6  10
 7t
2): (2.3)
Applying this estimate of thymic export to equations (2.1) and (2.2), rates of
cell division and loss ((t) and (t)) can be estimated without making any fur-
ther assumptions, by numerically estimating the rate of change of total cells
dN=dt. That is, the rate of growth of the total body naive pool is calculated
using the calculated total naive T cell numbers with age (Figure 2.1D). Where
the constant factor used to calibrate thymic output function directly scales our
estimates of the absolute values of peripheral production and loss in the pe-
riphery.
2.3 Results
The interdivision time of naive CD4+ T cells increases with an
individual’s age
If TRECs per naive cell are constant, as suggested by the data from Douek et
al. [1], the rate of cell division, (t), becomes proportional to thymic export and
inversely proportional to the size of the naive pool (see Appendix 2.5.3):
(t) =
c

  1
 (t)
N(t)
: (2.4)
Hence, to maintain the observed constant TREC frequency , the rate of suc-2.3 Results 47
cessful cell division in the periphery must decrease as thymic export wanes
with age. (t) is numerically estimated from equation (2.4) using the estimated
thymic export function (t) as deﬁned in equation (2.3) and observed naive T
cell numbers (Figure 2.1D). The mean interdivision time for naive cells, 1=,
is found to be approximately 125 days for children between the ages 1 and 5
years, or that approximately 0.8% of the population is dividing on any given
day. By age 20 years, the interdivision time is estimated to increase to approx-
imately 500 days (Figure 2.3A), corresponding to 0.2% of the population di-
viding per day. This is comparable with a rate of naive T cell production of
0.2% per day obtained from an in-vivo deuterated glucose labeling study in
young adults [64]. However, in vivo labeling studies are unable to distinguish
between cells that have recently divided in the thymus and post-thymic prolif-
eration. The observed rate of division from such studies is a composite of both
these processes and represents an absolute upper bound on .
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Figure 2.3: Estimated mean rate (solid black line) rate of successful naive CD4+
T cell division, (t) (panel A), and the mean rate of loss, due to death, change of
phenotype and migration, (t) (panel B) as functions of age t (assuming thymic
output of 6:8  107 CD4 cells per day at age 30.) Panels show mean and estimated
95th percentiles.
The expected residence or survival time of naive CD4+ T cells
increases with age
The expected rate of loss of naive T cells, is calculated from equation (2.2) and
the relation T(t) = N(t):2.3 Results 48
(t) =
1
N(t)

c

(t)  
dN
dt

: (2.5)
The denominator N(t) increases with age. Further, both thymic export ((t))
and the rate of growth of the naive T cell pool (dN=dt) are both (broadly) de-
creasingfunctionsofage; wherethethymiccomponentdominates sincec(t)=
is at least of the order 108 cells per day and our numerical estimates of the rate
of change of total naive T cells with age is of the order or less than 107 cells per
day after the age of 6 months. Thus (t) estimated using equation (2.5) above
is found to be a necessarily decreasing function of age (Figure 2.3B).
The expected residence time (1=) of a naive CD4+ T cell in the periphery is of
the order of 70 days between the ages 1-5 years, increasing to approximately
400 days by age 20 years, corresponding to a rate of death of 1.4% and 0.3%
of the population per day respectively (seen in Figure 2.3B). Assuming that the
system is in a quasi steady-state over short-time scales, ie. homeostasis, the rate
oflossisapproximatelyequaltotherateofproduction(peripheraldivisionand
thymic production). This is referred to as the rate of turnover. Our estimated
rate of turnover in young adults,  0.003 day 1, is in accord with the turnover
rate estimated in the deuterated glucose labeling study of Macallan et al. [64]
but is 5-fold higher than the estimate obtained by Vrisekoop et al using heavy
water [62]. The discrepancy between these studies is unresolved. However,
our estimates of the absolute rates of division and loss are directly dependent
on the estimated thymic export function, and scale linearly with the constant of
proportionality used to calibrate this function. Our conclusion that both rates
decline with age is independent of this scaling constant, however.
Between ages 0-20, the absolute daily contribution to the naive
CD4+ T cell population from peripheral division is greater than
the contribution from thymic export
From equation (2.4) and using the estimates c  0:25 and  ' 0:08, the total
number of cells produced by successful cell division in the periphery each day2.4 Discussion 49
is
(t)N(t) =
c

  1

(t)  2:1(t): (2.6)
The ratio c= is a measure of the TREC dilution that occurs due to proliferation
in the periphery. Equation (2.6) predicts that the daily contribution of periph-
eral division to the pool will necessarily be greater than that of thymic export
whenever c > 2. Experimental estimates of c and  imply that the contribu-
tion of cells to the naive pool through proliferation at any given age is at least
2-fold larger than the contribution from the thymus (Figure 2.4). Since both c
and  appear to be constant to age 20 years, equation (2.6) tells us that the ratio
of the total number of cells dividing per day to the total cells exported by the
thymus per day remains approximately constant until age 20 years.
2.4 Discussion
Our analysis makes three points. First, it suggests that in humans, despite their
decrease in frequency in the blood with age, total body numbers of naive CD4+
T cells grow almost continuously from (before) birth well into early adulthood.
Second, it shows that the mean interdivision time of these cells increases almost
continuously with age. This is in keeping with the conclusions of Hazenberg et
al.[2]whoshoweddivisionratesfallingbetweentheagesof0-5years; ouranal-
ysis predicts that this decline continues into adulthood. It has been reported
elsewhere that rates of naive T cell division are very low in adults [64, 136];
however, this study suggests that in children naive proliferation is relatively
vigourous, with an interdivision time of the order a few months. Third, it
shows that the net rate of exit from the naive CD4+ T cell pool (the combi-
nation of apoptosis, loss and differentiation) falls with age, or in other words
the mean residency time of a naive T cell increases with an individual’s age.
Since thymic export falls with age, together these results suggest that as the
naive T cell pool matures it becomes progressively less dynamic.
It is usually assumed that thymic export makes the dominant contribution to
the naive T cell population in children, but the study by Hazenberg et al. [2]2.4 Discussion 50
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Figure 2.4: Estimated mean absolute daily contribution of thymic export (solid
line), peripheral division (dashed line) and peripheral loss (dotted line) to the dy-
namics of the naive CD4+ T cell pool as a function of age, using the lower bound
on TREC content of RTEs; c=0.25.
showed that peripheral division also provides a substantial fraction of the daily
production of new cells. Our analysis conﬁrms and quantiﬁes this, up to age
20, at most 30% of the new naive cells that appear each day are produced in the
thymus. Interestingly, the invariance of TREC frequencies in peripheral naive
T cells suggests that this proportion remains ﬁxed during early life; there is
apparently no increase in rates of division in the periphery to compensate for
the drop in thymic production. One potential explanation for this apparently
stable relationship between the rate of thymic export and division is that recent
thymic emigrants may divide more rapidly than mature naive cells.
Density-dependent homeostasis?
Dutilh et al. [126] showed naive T cell TREC dynamics can be explained by
models of homeostasis in which rates of proliferation and/or loss are linked
to the size of the naive population; that is, these rates are density-dependent.
Such ecological models of the naive pool assume reasonably that as cell num-
bers increase, so should competition for resources and so rates of division fall
and rates of cell death increase. However, our results show that both the rates
of proliferation and loss (on a per-cell basis) fall with increasing pool size. This
raises the question of whether naive T cell competition is sensitive to cell den-
sities (e.g. cells per unit volume of blood), which fall with age, or to total body2.4 Discussion 51
numbers, which appear to increase with age. If proliferation is limited by com-
petition for signals or resources such as IL-7, our analysis suggests that the
likelihood of a cell dividing within a given time interval is limited by the naive
population size rather than the naive cell density in blood. It has also been ar-
gued that naive CD4 populations may be regulated at the level of individual
clone size rather than total cell numbers [137], perhaps through competition of
cross-reactive TCRs for overlapping ’niches’ of self-peptide MHCII complexes
in the periphery.
The picture is less clear in the case of cell loss, since here (and in other models)
the naive CD4 T cell loss rate (t) is a combination of death, differentiation to
effector or memory phenotypes, or permanent loss from circulation. Here the
effects of these factors can not be isolated, and so it is not possible to assess
how rates of apoptosis induced by homeostatic resource limitation depend (if
at all) on cell numbers.
Phenotypic heterogeneity and clonal diversity in the naive T
cell pool
Despite the slow increase in naive T cell numbers over the timescale of
years, over short timescales (days or weeks) the pool is in a state of ’quasi-
homeostasis’, where the number of cells lost or displaced from the naive pool
each day is approximately equal to thymic production and peripheral division
combined. However, our model tells us nothing about whether this displace-
ment occurs randomly or whether some naive subpopulations have a selective
advantage. One strong possibility is that there may be heterogeneity in ex-
pected survival time with respect to the time since the last division. Vrisekoop
et al. [136] performed isotope-labelling assays in healthy young adult volun-
teers and found that newly produced cells (i.e. cells that had taken up label, ei-
ther through division in the thymus and export soon after or through division
in the periphery) were lost at a very low rate – much lower than the rate of suc-
cessful division. This implies that recently divided naive cells have a survival
advantage over the average cell in the pool as a whole. Thus one would pre-2.5 Appendices 52
dict that as division rates fall with age, average loss rates would increase – not
decrease, as our analysis indicates. To resolve this apparent inconsistency re-
quires that the per-cell loss rate of naive T cells depends both on time since last
division and also on an individual’s age, either explicitly or indirectly through
(for example) population or clone size. This suggests a two-layered mecha-
nism for maintaining clonal diversity in the naive T cell pool; the aim being
(i) to provide recent thymic emigrants, which are costly to produce and help
to increase our TCR repertoire, with a survival advantage and (ii) to increase
naive cell longevity as thymic output wanes. Precisely how this regulation of
cell loss is regulated with age, however, remains an open question.
Together these results suggest a more complex, structured picture of naive T
cell dynamics thaN has perhaps previously been considered. Per-cell division
rates may vary as a function of age, total naive T cell numbers or cell density,
through resource competition. They may also vary as a function of time since
thymic export. Further, survival may depend on the time since last division as
well as resource availability. How then do the signals T cells receive from their
environment translate into survival or proliferative beneﬁts? Since IL-7 is re-
quired for both naive T cell survival and division, cells that have accumulated
sufﬁcient signal to divide may well have the additional beneﬁt of a survival
advantage through (for example) accumulation of anti-apoptotic factors. In-
terestingly, memory T cell populations appear to follow different rules; in the
CD4+CD45RO+ population, recently-divided cells appear to be more prone to
apoptosis than quiescent cells [61].
2.5 Appendices
2.5.1 Calculating the distribution of total body naive CD4+ T
cells with age
Linderkamp et al. [129] reported the following linear relationship:
log (blood volume (l)) = 0:97 log (body weight (kg)) + 4:93; (2.7)2.5 Appendices 53
where the standard error on the slope is 0.05. Average body weight as a func-
tion of age is determined using standard growth charts for healthy children,
published by the CDC [128]. Speciﬁcally, for ﬁxed age t, we repeat the follow-
ing:
1. Draw the logarithm of body weight, logW(t), from a normal distribution
with mean log(W50(t)) and estimated standard deviation
 =
1
4
log

W97(t)
W3(t)

;
where Wi(t) is the i-th percentile of body weight at age t [128] (Fig-
ure 2.1A);
2. Calculate a blood volume V (t) using the body weight logW(t) generated
in the previous step; V (t) is drawn from a lognormal distribution with
mean given by equation (2.7) and standard deviation calculated from the
standard error on the slope of the regression line (the distribution of total
blood volume across individuals by age, obtained by combining steps 1
and 2, is shown in Figure 2.1B);
3. Calculate naive (CD45RA+) CD4+ T cell density per microlitre of blood,
(t), from the ﬁtted relationship calculated by [103] (Figure 2.1C):
(t) = 496 + 2074exp( 8:75  10
 4t);
with upper and lower 95% bounds deﬁned as (
(t)
3 , 2(t)). Draw values
for (t) from a lognormal distribution with parameters  = Log[ (t)] - 0.1
and  = 0.45, chosen to ﬁt a mean of (t) and 95% interval as deﬁned
above.
4. Total body naive (CD45RA+) CD4+ T cell numbers are then estimated
from their blood density using N(t) = 50(t)V (t), with the factor 50 ac-
counting for the estimated 2% of naive cells in the blood at any time.2.5 Appendices 54
From the empirical distribution generated by repeating steps 1-4, the mean val-
ues for total body naive CD4+ T cell numbers at age t, along with the estimated
2.5% and 97.5% quantiles are estimated. This procedure is then repeated for
ages in the range 0-20 years (Figure 2.1D).
2.5.2 Modelling the age-dependent distribution of naive T cells
between blood and secondary lymphoid organs
An important assumption of our study is that the proportion of the naive T
cell pool found in the blood is independent of age. However, Watanabe et
al. [138] show that the ratio of spleen volume to body weight declines slightly
from the age of 0 to 20 years. If it is assumed that lymphoid tissues grow
proportionally with the spleen, then their results suggest that percentage of
lymphocytes found in the blood increases linearly from approximately 1% at
birth to 2% at age 20 years.
When this is included in the analysis, a more rapid expansion of total body cell
numbers is observed early in life, approaching a mean of 1:3  1011 cells by the
age of 2 (Figure 2.5). In terms of predicted rates of cell production and loss this
translates into slower dynamics, however, we still expect to see a general de-
cline in both rates with age, although the drop is less steep. In terms of absolute
values, the predicted total number of cells produced each day does not change
as this is simply a function of our estimated thymic function (equation 2.6). The
total number of cells lost from the naive pool is marginally lower between the
ages of 0 to 5 to allow a steeper rate of cell population growth at this younger
age. Figure 2.5 D illustrates that although the size of the total naive pool is
sensitive to the assumption about proportion of lymphocytes found in periph-
eral blood, the predicted rate of cell production and loss (cells/day) are fairly
robust to changes in this assumption.2.5 Appendices 55
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Figure 2.5: Measuring sensitivity to proportion of cells found in lymph nodes: A:
Total body naive population as a function of age. B: Predicted rate of proliferation.
C:Predictedrateofloss. D:Predictedabsolutenumberofcellsexportedbythymus
(solid line), produced in periphery (dashed) and lost from naive pool (dotted line).
(Calculated assuming the proportion of cells in the blood increases linearly from
1% at birth to 2% at age 20 (dark line); ﬁxed 2% for all ages (grey line))2.5 Appendices 56
2.5.3 Modelling constant TREC densities
The observation that the TREC content per naive CD4 T cell, T(t)=N(t) is a
constant, , implies
d
dt

T
N

= 0 =)
1
N

dT
dt
 
T
N
dN
dt

=
1
N

dT
dt
  
dN
dt

= 0: (2.8)
Equation (2.4) is obtained by substituting the expressions for dN=dt and dT=dt
from equations (2.1) and (2.2) respectively.Chapter 3
Quantifying Thymic Export:
combining models of naive CD4+ T
cell proliferation and TREC
dynamics gives an explicit measure
of thymic outputAbstract
UnderstandingT-cellhomeostasisrequiresknowledgeoftheexportrateofnew
T-cells from the thymus; a rate that has been surprisingly difﬁcult to estimate.
In the previous chapter the relative contributions of peripheral post-thymic di-
vision and thymic export to the dynamics of the naive T cell pool were ex-
plored. In line with previous studies, it was assumed that thymic volume was
directly correlated to thymic output and estimated the number of T cells ex-
ported per day by scaling a function ﬁtted to thymic epithelial space (TES)
volume with age. Here an alternative method for quantifying thymic export in
humans on an individual basis, by combining two simple mathematical mod-
els, is presented. One model uses Ki67 data (from Douek et al. [1] and Hazen-
berg et al. [2]) to calculate the rate of peripheral naive T-cell production whilst
the other tracks the dynamics of T cell receptor excision circles (TRECs) (data
from Douek et al. [1]) . TREC content has been used as a proxy for thymic ex-
port, but this quantity is inﬂuenced by cell division and loss of naive T-cells
and is not a direct measure of thymic export. Combining these models allows
the contributions of the thymus and cell division to the daily production rate
of T cells to be disentangled. The method is illustrated with published data on
Ki67 expression and TRECs within naive CD4+ T cells in healthy individuals.
A quantitative estimate for thymic export is obtained as a function of age from
birth to 20 years. This analysis shows that the export rate of T cells from the
thymus follows three distinct phases: an increase from birth to a peak at 1 year
followed by rapid involution until around 8 years and then a more gradual
decline until 20 years.3.1 Introduction 59
3.1 Introduction
The thymus is the primary source of naive T cells and plays a key role in es-
tablishing and maintaining the peripheral T cell pool. In children, the T cell
compartment grows continuously with age from birth to adulthood. Cell num-
bers then remain approximately stable throughout adult life. During the ﬁrst
20 years of life the thymus is known to involute and its output is supplemented
by division within the existing peripheral naive T cell pool [1,8,53,61]. How-
ever, the absolute contribution of the thymus to the peripheral naive cell pool
and how this contribution changes with age is difﬁcult to measure. Despite
a wide array of immunological markers, imaging techniques and histological
studies, we still lack a direct quantitative measure of thymic export and are un-
able to answer some basic questions about the contribution of the thymus to
lymphocyte homeostasis in health and in disease.
In humans, much of our knowledge of the thymus comes from biopsy studies.
Steinmann and colleagues [8] showed that the thymus reaches its maximum
volume by 1 year of age and then remains constant, but the relative size of
the intra-thymic compartments changes substantially with age. The thymic ep-
ithelial space (TES) involutes by 70% over the ﬁrst 20 years accompanied by a
simultaneous expansion of the perivascular space, connective and adipose tis-
sue. As the TES is the main site of thymopoeisis and the majority of thymocytes
are found in this region, it is inferred that that the functionality of the thymus
must involute continuously with age. In chapter 2, TES volume was scaled to
predict changes in thymic export with age, in accord with other studies [126],
however, it is not obvious that the volume of the TES is directly proportional to
the total rate of export of T cells to the periphery. The TES is a site of extensive
expansion and selection where less than 5% of cells survive the development
process and any minor changes in the rate of production or loss of cells may
have a large impact on the rate of export [5–7]. In fact, even the decline in cel-
lular density of thymic tissue with age, does not appear to directly parallel the
changes in TES [139].3.1 Introduction 60
In-vivo isotope labelling has been useful for quantifying lymphocyte turnover
in the naive CD4+ T cell population in adults [62, 64], but there are difﬁcul-
ties associated with using this approach to quantify thymic export and the rate
of involution. The method does not allow cells dividing in the periphery to
be distinguished from those that divided in the thymus and emigrated to the
periphery during the period of label administration.
T cell receptor excision circles (TRECs), the cell surface marker CD31 and,
more recently, protein tyrosine kinase 7 (PTK7) expression by peripheral T
cells have been used as surrogate markers for thymic export. TRECs are sta-
ble, non-replicative extra-chromosomal circles of DNA excised during T cell
receptor gene rearrangement [51,52,140]. TRECs are produced in the thymus
and can be measured in peripheral CD4+ and CD8+ T cells. CD31 identiﬁes
a subset of naive cells which is signiﬁcantly enriched with TRECs [55]. PTK7
is expressed at high levels on mature CD4+ CD8  thymocytes and a subset
of naive CD31+ CD4+ T cells which is highly enriched for TRECs [3]. Both
the TREC content and the proportion of recent thymic emigrants within the
naive pool, deﬁned by CD31 or PTK7 expression, are known to decline with
age [3,52,55,56,112,133]. However, these observations reﬂect a combined con-
sequence of changing thymic export, cell division, and longevity of thymic
emigrants and cannot therefore give a strict measure of declining thymic ex-
port [53,56,126,141–143].
Ki67 is a nuclear cell cycle marker that is expressed only in proliferating cells
from late stage G1 and is rapidly degraded on exit from cycle [144,145]. Ki67
expression coincides with the deterministic phase of cell cycle [146–148] and
provides a good estimate for the fraction of dividing cells at any given time.
The level of proliferation within the naive CD4+ T cell pool as determined by
Ki67 expression declines with age [1, 2] and this must be taken into account
when using the surrogate markers above to infer changes in thymic function
over time.
In this work, thymic export is investigated by considering expression of both
Ki67 and TRECs within the naive CD4 T cell population. The concentration3.2 Mathematical model 61
of TRECs per naive cell is a function of both thymic export and peripheral cell
division and in chapter 2 a mathematical model was used to identify a relation-
ship between these two contributing factors. A model of Ki67 expression data
is used to quantify the contribution of peripheral expansion and applied to the
model of TREC concentration to extract a quantitative estimate for the rate of
thymic export.
Resting Naïve Cells
(Ki67-)
X(t)
Dividing Naïve Cells
(Ki67+)
Y(t)
transition in to
cell cycle
2 daughter cells
return to rest
  
a(t)
  
r(t)
Thymic Export
  
 (t)
cell loss
  
 X(t)
cell loss
  
 Y(t)
Figure 3.1: A simple model of naive CD4+ T cell dynamics. The naive population
is divided into two compartments according to cell cycle status; at rest or dividing,
where Ki67 expression is used as a surrogate marker for dividing cells.
3.2 Mathematical model
A mathematical model is described, combining TREC dynamics with naive T
cell turnover (in turn measured by Ki67 expression), to allow thymic export
from birth to adulthood to be quantiﬁed. Ki67 expression provides an inde-
pendent, quantitative estimate of post-thymic production of naive CD4+ T cells
through peripheral cell division. This estimate is then substituted into a model
of TREC dynamics to obtain an explicit expression for thymic export in terms
of number of CD4+ T cells that are exported per day. Ki67 expression and
TREC content have been described in the naive CD4+ T cell population as it
grows from birth to adulthood. These data are used with the model to estimate
thymic output over the ﬁrst 20 years of life.3.2 Mathematical model 62
Using TRECs to determine the relative contributions of thymic
export and post-thymic expansion
As in chapter 2, a model initially presented by Hazenberg et al. [53] is adapted
to interpret the expression of TRECs by simultaneously studying two pools;
total body naive T cells and total body TRECs. The total naive CD4+ T cell
population at age t, N(t), is described by a general population growth model
allowing for cells emigrating from the thymus, expansion through peripheral
division and cell loss through death, change of phenotype or migration out of
the peripheral pool. From here on ’loss’ is taken to be a combined function of
all the process that lead to loss of naive cells from the peripheral system. The
growth of the naive T cell population with age is described as follows:
dN(t)
dt
= (t) + (t)N(t)   (t)N(t) (3.1)
where (t) represents the rate of thymic export (number of CD4+ T cells ex-
ported per day in an individual of age t); (t) (day 1) is a per-cell rate of ad-
dition to the naive population through peripheral division at age t, approx-
imately the inverse of the mean interdivision time of a naive cell; and (t)
(day 1) is the average rate of naive cell loss at age t, where 1=(t) is approx-
imately the expected residence time of a cell in the peripheral naive pool.
The following assumptions are used to deﬁne the dynamics of total body
naive TRECs: (i) TRECs are exclusively produced following TCR gene re-
arrangement within the thymus [52]; (ii) cell division does not result in the
loss or creation of TRECs [52]; and (iii) intracellular degradation of TRECs is
negligible [52,132,140]. These assumptions imply that the loss of naive TRECS
is exclusively associated with the loss of naive T cells. Further, it is assumed
that the rate of loss is homogeneous with respect to TREC content and that the
average rate of naive CD4+ T cell loss is equal to the average rate of naive TREC
loss, as described by other investigators [2]. Changes in total naive TRECs with3.2 Mathematical model 63
age can then be described by
dT(t)
dt
= c(t)(t)   (t)T(t); (3.2)
where T(t) represents the total number of TRECs in an individual age t, c(t) is
the average TREC content of CD4+ T cells emerging from the thymus, and (t)
and (t) are deﬁned above.
Jamieson et al. [132] showed that the TREC content of thymocytes remains con-
stant with age, however, this is found not to be the best quantitative estimate
for TREC content of cells emigrating from the thymus as it is measured in un-
sorted thymocytes and includes cells that have yet to undergo T cell receptor
rearrangement and does not account for division within the thymus before ex-
port. Junge et al. [133] reported on average 250 sjTRECs per 1000 recent thymic
emigrants (CD31+ CD4+ T cells) in cord blood. As discussed in chapter 2, this
represents a lower bound on c as any post-thymic division results in dilution
of TRECs. It has been shown that approximately 3 divisions occur within the
thymus between the production of signal-joint and coding-joint TRECs [52].
Given that it is possible to produce at most 2 sjTRECs per cell if rearrangement
occurs in both alleles, one can argue that a maximal value for c would be 0.25.
In the following calculations it is estimated that c=0.25.
TRECs are generally measured and reported as a number per g of T cell DNA.
This can be translated into an average number per cell using the assumption
that 1g of T cell DNA represents approximately 150,000 T cells. Deﬁne a new
variable (t) (= T(t)=N(t)) to measure the average number of TRECs per naive
CD4+ T cell. Equations (3.1) and (3.2) can be brought together to obtain an
expression for rate at which (t) changes with age (see appendix 3.5.1):
d(t)
dt
=
(t)
N(t)
(c   (t))   (t)(t): (3.3)
It is observed that the TREC content per naive cell will increase with increas-
ing thymic export (t) and decrease with increasing peripheral division (t).
Douek et al. [1] calculated TREC frequencies in naive CD4+ T cells in individu-3.2 Mathematical model 64
als aged 0 to 80 using total measured CD4+ TRECs and the percentage of naive
T cells, assuming that memory (CD4+ CD45R0+ ) T cells contain only 2% of
TRECs. Their observations suggest that there is no signiﬁcant change from the
age of 0 to 20 (p=0.1) and, as in chapter 2, the mean TREC content per naive
cell over this period, (t), is estimated to be 0.08  0.01 (std. error). This con-
servation of TRECs during the ﬁrst two decades of life has also been observed
in CD8+ naive T cells [130] and in PBMCs [131].
The following expression for thymic export in terms of the average TREC con-
tent per naive cell and the rate of peripheral cell division is obtained from equa-
tion (3.3):
(t) =

(t)(t)N(t) +
d(t)
dt
N(t)

1
c   (t)
: (3.4)
In order to extract a quantitative estimate for thymic export, (t), an estimate
for both the number of cells added to the naive pool through peripheral cell di-
vision each day ((t)N(t)) and the rate of change of the TREC content per naive
cell with time (d=dt) is required. It can be argued that the latter term is negligi-
ble since the average content per naive cell is approximately constant between
ages 0-20 (see appendix 3.5.2). In the following section, Ki67 expression data is
used to estimate the contribution of peripheral division.
Using Ki67 expression to estimate the contribution of periph-
eral division
Ki67 is a proliferation marker expressed from late stage G1 through to the end
of mitosis [144]. Upon exit from cell cycle, it is rapidly degraded with a half-life
of approximately 1 hour, independent of cell cycle position on exit from cycle
[145]. Ki67 is therefore used to partition the naive CD4+ population according
to cell cycle status (at rest or cycling) and a two compartment model [119,149]
is used to estimate the rate of addition of new cells to the naive population
through peripheral division. This model is illustrated in Figure 3.1.
Total naive T cell numbers are dependent on export of cells from the thymus,
peripheral cell division and loss through death, differentiation or migration3.2 Mathematical model 65
out of the system. A simple dynamical model can be used to describe how
total numbers of resting, X(t), and dividing, Y (t), naive CD4+ T cells change
with time:
dX(t)
dt
= (t) + 2r(t)Y (t)   (a(t) + X(t))X(t); (3.5)
dY (t)
dt
= a(t)X(t)   (r(t) + Y(t))Y (t); (3.6)
where cells enter the resting naive cell compartment from the thymus at rate
(t) (cells day 1), resting cells enter cell cycle at rate a(t), and are lost irre-
versibly from the naive resting pool at rate X(t). The dividing population has
its own rate of cell loss, Y(t), and cells revert to the resting state at rate r(t).
All rates have units of days 1. It is assumed that upon completion of cell cycle,
two daughter cells will return to the naive resting pool.
In this model, the total number of naive cells is equal to the sum of the resting
and dividing compartments and hence:
dN(t)
dt
=
d[X(t) + Y (t)]
dt
(3.7)
Combining equations (3.1), (3.5) and (3.6) gives:
(t) + (t)N(t)   (t)N(t) = (t) + r(t)Y (t)   X(t)X(t)   Y(t)Y (t)(3.8)
where total loss of naive cells, (t)N(t), is assumed to be equal to the com-
bined loss from the resting and dividing compartment, X(t)X(t)+Y(t)Y (t).
It is inferred from equation (3.8) that the number of cells added to the naive
population through cell division in the periphery each day, (t)N(t), is equal
to r(t)Y (t). The rate of reversion of dividing cells to the resting pool, r(t), can
be interpreted as the inverse of average time spent expressing Ki67 during one3.2 Mathematical model 66
complete cell cycle, 1= (an alternative modelling approach gives comparable
results and is described in appendix 3.5.3):
Contribution of peripheral cell division (cells/day) = (t)N(t) = r(t)Y (t) 
Y (t)

=
total number cells expressing Ki67
duration of Ki67 expression
:
Ki67 is expressed in late stage G1, S, G2 and M phase of cell cycle [144,145].
The majority of variability in cell cycle duration is thought to arise from the
length of G1, whereas the period of Ki67 expression coincides with the more
deterministic ’B-phase’ of cell cycle which is thought to be associated with a se-
quence of known physiological events of conserved length [146–148,150]. Gett
and Hodgkin [66] determined the average division time of stimulated naive
CD4+ T cells to be 12.4 hours (1:0 hours), it can be argued that this reﬂects
the minimum time taken for a naive cell to divide, and hence complete the de-
terministic phase of cell cycle, and let  be constant with mean 0.52 (day 1).
This is likely to be an upper bound on , since it also includes some time in
interphase.
The total number of cells produced through cell division per day is estimated
by combining data for Ki67 expression as a fraction of naive CD4+ T cells, y(t),
with predicted total body naive cell numbers, N(t):
Contribution of peripheral cell division (cells/day)
(t)N(t) 
y(t)N(t)

=
y(t)(t)V (t)
0:02 
(3.9)
where y(t) is the fraction of naive CD4+ T cells expressing Ki67 such that
Y (t) = y(t)N(t) (Figure 3.2A, data taken from studies by Hazenberg et al. [2]
and Douek et al. [1]); (t) is the naive CD4+ T cell count per unit volume
of blood [103] and V (t) is the predicted total blood volume at age t. As in
the previous chapter (Appendix 2.1), blood volume is estimated using a rela-
tionship between blood volume and body weight described by Linderkamp
et al. [129], where standard body weight was estimated using standard CDC3.3 Results 67
growth data [128]. Lymphocytes in the blood are taken to represent 2% of all
body lymphocytes [23], and Ki67 expression is assumed to be homogenous be-
tween blood and lymph nodes. The latter assumption is given some support
by Fleury et al. [151] who found that the percentage of CD4+ T cells expressing
Ki67 in healthy individuals was 1.06% in the blood compared to 0.75% in the
lymph nodes.
The 2.5 and 97.5 percentiles for the total daily contribution of peripheral divi-
sion to the naive CD4+ T cell pool are obtained by combining the distributions
of the three components. This procedure is outlined in appendix 3.5.4.
An expression for thymic export
An explicit expression for thymic export in terms of total naive cell numbers,
naive cell TREC content and Ki67 expression is obtained by combining equa-
tions (3.4) and (3.9), as follows:
Thymic Export (cells day 1) = (t) 
y(t) N(t) 
 (c   )
; (3.10)
where (as deﬁned above) y(t) is the fraction of naive CD4+ T cells expressing
Ki67, N(t) is the total naive CD4+ T cell population,  is the duration of Ki67
expression, and  and c are constants representing the average TREC content
of the peripheral naive CD4+ T cell population and thymocytes entering the
peripheral naive population, respectively. Each of these parameters can be di-
rectly estimated using T cells sampled from peripheral blood.
3.3 Results
Quantifying peripheral post-thymic production as a function of
age
Studies show that Ki67 expression in the naive CD4+ T cell population declines
from birth to age 30 years [1,2]. Experimental Ki67 data from Douek et al. [1]
and Hazenberg et al. [2] (Table 3.1) is combined and ﬁtted to an exponential3.3 Results 68
decay function, aexp( ct) (age t in years), where a = 0.02 (0.012, 0.03) and c =
0.1 (0.03, 0.28) (95% conﬁdence intervals in parentheses; Figure 3.2A).
The total number of dividing naive CD4+ T cells as a function of age, Y (t), was
estimated by combining this decay function with an estimate of total periph-
eral naive CD4+ T cell numbers derived in chapter 2. This was used in equation
(3.9) to calculate the expected total number of cells added to the naive popu-
lation each day through peripheral cell division, between ages 0 to 20 years
(Figure 3.2B). Although the proportion of naive CD4+ T cells expressing Ki67
declines monotonically with age, peak production in terms of absolute num-
bers of cells added to the naive pool each day occurs at age 1 year. The mean
peripheral naive CD4+ T cell production is predicted to be 2.8x109 (7.8 x108, 6.9
x109) cells per day at age 1, dropping to 6.8x108 (2 x107, 4.1x109) cells per day
in individuals aged 20 (parentheses indicate estimated 2.5 and 97.5 percentiles
at the population level). This corresponds to a continuous decline in the rate of
division; 3.7% of the naive CD4+ T cell population is dividing per day at birth,
this drops to 0.5% by age 20. The rate of decline in naive T cell production
is comparable to the Ki67-independent estimates from the previous chapter;
from 2% at birth to 0.2% at age 20. It is also in accord with estimates of naive
production rates from deuterated glucose labelling studies in young adults of
0.2% [64].
Quantifying thymic export as a function of age
Ki67 expression and TREC content within the naive CD4+ T cell population
is used to obtain a continuous estimate for thymic export from birth to age 20
years (Figure 3.3). The life history of a healthy thymus appears to comprise
three distinct stages; the rate of thymic export increases during the ﬁrst year
of life, rapidly diminishes between the ages of 1 and 8 years, and then slowly
declines from about age 8 years onwards. This trend directly follows the age-
dependence of peripheral T cell production by proliferation (Figure 3.3B) and
is a consequence of the growth of the naive compartment with age whilst main-
taining constant TREC content within the naive pool [1].3.3 Results 69
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Figure 3.2: A: Fraction of naive CD4+ T cells expressing Ki67 (data taken
from Hazenberg et al. [2] & Douek et al. [1]) ﬁtted to an exponential decay;
0:02 exp( 0:1t) (t measured in years), B: Estimated number of naive CD4+ T cells
generated by peripheral division per day. Mean (solid line), 2.5% and 97.5% per-
centiles (dashed lines).
Using this approach the average thymus is predicted to export 6.9x108 CD4+
T cells per day at birth (1.3x108, 2.5 x109), a rate that doubles during the ﬁrst
12 months of life to yield a daily export of approximately 1.4x109 CD4+ T cells
per day at 1 year (2.7x108, 5x109). This is consistent with histological studies
showing that the human thymus continues to grow during the ﬁrst year of life,
reaching maximal volume at 1 year [8] and peak cellular density at 9 months
[139,152]; it is not altogether surprising as this period coincides with a time of
rapid growth of the entire body and maturation of the immune system along
with the decline in maternal antibody protection.
The biphasic decline in thymic export from ages 1 to 20 years is consistent with
the decline predicted by the histological study of Steinmann et al. [8] (Figure
3.3B). There is a rapid contraction from age 1 to 8 years corresponding to an3.3 Results 70
average decline in output of 12% per year1 which is somewhat faster than the
involution predicted by changes in the volume of TES with age. Following on
from this rapid decay, there is a slower involution phase from about 8 years
onwards which follows the involution of TES volume more closely. During
this phase, thymic output drops from 5.6x108 (0.7x108, 2.5x109) to just under
3.5x108 (0.1x108, 2.7x109) CD4+ T cells per day by age of 20, corresponding to
an average involution rate of 4% per year.
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Figure 3.3: A: Estimated rate of thymic export of CD4+ T cells (cells/day): mean
(solid line) and 2.5% and 97.5% percentiles (dashed lines), B: Thymic involution
predicted by mean thymic export (solid line) and relative volume of thymic epithe-
lial space allowing for growth during ﬁrst year of life, scaled to maximal volume
(dashed line) [8].
Thymic involution to age 60 years
The model is extended by considering the changes in naive CD4+ T cell num-
bers, TRECs and Ki67 expression in healthy subjects to age 60 years. A number
of studies have reported that the size of the naive CD4+ T cell population and
1average annual rate of involution, x, estimated by (t1) = (t0)(1   x)t1 t03.4 Discussion 71
fraction of naive CD4+ T cells expressing Ki67 remains fairly constant from
age 20 to 60 years [1,70,102,103]. Meanwhile, the number of TRECs per naive
CD4+ T cell are observed to decline signiﬁcantly from age 20 years onwards
(Table 3.2; data from Douek et al. [1]). The model is used to interpret the data
as before (equation 3.4), only naive TRECs are allowed to vary with age, as
shown in Figure 3.4C.
The model predicts that thymic output declines almost linearly from age 20 to
60 years; average output is projected to drop by 96% from just under 3x 108
at age 20 to  1x107 cells per day by age 60 years; corresponding to an annual
rate of involution of 8% per year. This is comparable to a 95% decline in the
number of TRECs per naive T cell over the same period [1]; an 80% decline in
TES volume [8]; a 90% drop in the fraction of PTK7+ naive T cells [3]; a 50%
decline in the fraction of CD31+ naive CD4+ T cells in the CD4+ T cells and a
simultaneous  2-fold drop in the number of TRECs per CD31+ naive CD4+ T
cell [56].
3.4 Discussion
Using mathematical modelling to analyse cell population dynamics, a quanti-
tative estimate for thymic export is obtained using CD4+ naive T cell counts,
TREC density and Ki67 expression within the naive population. It is shown
that the number of cells exported by the thymus per day doubles during the
ﬁrst year of life and then declines in a biphasic manner throughout childhood;
the most extensive decline in production is observed between the ages of 1 and
8. Following a slack period between the age of 10 and 20 years, thymic invo-
lution continues at a steady, almost linear rate, from age 20 to 60 years. In the
previous chapter, the density of TRECs within the naive population was mod-
elled to infer a relationship between the relative contributions of thymic export
and peripheral cell division to the naive CD4+ T cell population. The relative
changes in naive production and loss with age were investigated based on the
assumption that thymic export followed the involution of the TES. However,
it was not clear that TES volume would necessarily directly correlate to the3.4 Discussion 72
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Figure 3.4: A: Naive CD4+ T cell density in blood (cells/l), as described by Hue-
necke et al. [103]; B: Fraction of Ki67+ naive CD4+ T cells, as measured by Hazen-
bergetal.[2]andDoueketal.[1], ﬁttedtoasimpleexponentialdecay; C:Observed
TRECs per naive CD4+ T cell, as measured by Douek et al. [1], ﬁtted to a linear de-
cay; D: Predicted thymic output (cell/day). Mean (solid line) and 2.5% and 97.5%
percentiles (dashed lines).3.4 Discussion 73
number of cells exported to the periphery each day. In addition, assessing TES
volume requires careful study of biopsied thymic material and is not a partic-
ularly tractable technique for assessing thymic export on an individual basis.
In this work an alternative approach, relying on peripheral blood markers, is
used to quantify thymic output.
Combined production of naive CD4+ T cells through cell division and thymic
export is predicted to be  1.0x109 cells per day at age 20 years, this is com-
parable to estimates of total production in young healthy volunteers of 1.3x108
naive CD4+ T cells per day as measured by in-vivo heavy water labelling stud-
ies [62], and 5.7x108 cells per day obtained by deuterated glucose labelling [61].
The pattern of thymic involution predicted by the TES [8] is found to correlate
well to our predicted change in thymic output to age 20 years (Figure 3.3B).
From age 20 years onwards, the model predicts a rate of involution of thymic
output of 8% per year that somewhat exceeds the decay predicted by TES
volume of 4% per year, suggesting that the number of T cells exported may
not be directly correlated to volume of thymic tissue.
The TREC concentration of thymic emigrants must be estimated in order to
model TREC dynamics within the peripheral naive CD4+ T cell population.
Previous studies suggest that this is stable with age from 0 to 60 years [52,132],
although, the value of this concentration can not be directly measured and is
a source of uncertainty in our estimates. For the purpose of this study, it is
argued that this equals 0.25 based on the TREC content of recent thymic em-
igrants (CD31 expressing naive CD4+ T cells) in neonates [133] and the ob-
servation that 3 divisions occur within the thymus following the formation of
sjTRECs [52]. An upper bound for the TREC concentration in thymic emigrants
is determined from the TREC concentrations measured in CD4+ single positive
thymocytes (0.6, ref [134]); this is a conservative estimate since proliferation is
known to occur at the single positive stage of thymocyte development [153].
The choice of this parameter scales our estimates for thymic export, although
the scaling is independent of age; taking the maximal value of this parameter
to be 0.6 gives a three fold lower estimate for thymic export than our estimate3.4 Discussion 74
of 0.25.
Another potential source of uncertainty in our estimates as discussed above is
the duration of Ki67 expression. This period coincides with the deterministic
B-phase of cell cycle and it was assumed that it is ﬁxed at approximately 12
hours [66], alternative experimental estimates for the length of CD4+ T cell
cycle vary from 12 hours to 20 hours [67]. This parameter scales our estimates
for both peripheral production and thymic export and is something that could
be more accurately determined by experiment. This does not inﬂuence the
predicted rate of decline in production with age; however, taking an upper
and lower bound on Ki67 expression to be 20 and 12 hours, leads to predicted
thymic export of 2.1x 108 and 3.5x108 cells per day at age 20, respectively.
Residual expression of Ki67 on thymic emigrants is a possibility, however, the
extent to which this will inﬂuence our estimates for peripheral production is
limited by the rapid loss of Ki67 upon exit from cell cycle [145]; even if all
cells exit the thymus immediately on completion of cell cycle, a half-life of 1
hour means that Ki67 expression resulting from thymic emigrants would still
be negligible compared to expression resulting from peripheral division.
In this work, a method was derived for explicitly quantifying thymic export
using parameters that can be directly measured from peripheral blood. When
modelling in vivo lymphocyte dynamics there is always a need to translate
the parameters that are observed in peripheral blood to the entire lymphatic
system. In this study, an important assumption is made that the systems are
homogeneous. This is justiﬁed by the observation that there is no signiﬁcant
difference between TREC concentrations in lymph nodes as compared to pe-
ripheral blood in healthy individuals [154], and Ki67 expression has also been
observed to be similar in both compartments [155].
In order to estimate total body cell numbers it is assumed that at any given
time only 2% of lymphocytes will be found in the blood. The decline in the fre-
quency of naive T cells in blood with age is well-established [103,156] although
there exists signiﬁcant variation between individuals. This inter-individual3.5 Appendices 75
variation is compounded when estimates are scaled up for the lymphatic com-
partment and accounts for a large component of the variance that is predicted
at the population level.
If our understanding of normal thymic export in health is limited, then the
role of the thymus in disease is even less understood. Premature involution
of thymic volume is associated with rapid disease progression in human im-
munodeﬁciency virus (HIV) infected children [157] but it is not known if this
reduction in thymic volume reﬂects reduced thymic export and some older
HIV-infected individuals show increases in thymic volume compared to age-
matched healthy controls [158]. A better measure of the number of cells ex-
ported by the thymus is required to properly understand the role of the thy-
mus in disease progression and T cell reconstitution following antiretroviral
therapy. TREC levels are decreased in HIV-infected individuals [1] but it was
shown that this largely reﬂects an increase in the rates of peripheral division
rather than decreased thymic output [53, 159]. Here a method is presented
to estimate thymic export using peripheral TREC and Ki67 expression data
in healthy individuals that allows us to explore the natural involution of the
thymus with age and provides a step towards better understanding the contri-
bution of the thymus to the nature of T cell reconstitution occuring following
chemotherapy, hematopoieticstemcelltransplant, thymicimplantortreatment
with anti-retroviral therapy in HIV.
3.5 Appendices
3.5.1 Derive an expression for
d(t)
dt
Let (t) equal to T(t)=N(t) and consider the derivative of (t):
d(t)
dt
=
N(t)
dT(t)
dt   T(t)
dN(t)
dt
N(t)2 (3.11)3.5 Appendices 76
Equation (3.3) is obtained using the derivative of N(t)and T(t) as determined
by equations (3.1) and (3.2):
d(t)
dt
=
N(t)(c (t)   (t)T(t))   T(t)((t) + (t)N(t)   (t)N(t))
N(t)2 (3.12)
=
(t)
N(t)
(c   (t))   (t)(t) (3.13)
3.5.2 Validate assumption that
d(t)
dt = 0
From equations (3.4) and (3.2) (an expression for thymic export is obtained in
terms of the size of the total naive pool, N(t), the proportion of dividing cells,
y(t), and the rate at which the average TREC content per naive cell changes
with time:
(t) =

y(t)(t)

+
d(t)
dt

N(t)
c   (t)
(3.14)
where c is the average TREC content of thymocytes leaving the thymus and 
is average length of Ki67 expression, both of which are assumed to be constant.
The TREC content per naive CD4+ T cell was found to be approximately ﬁxed
from birth to age 20 years by Douek and colleagues [1]. A number of studies
suggest that the average per cell TREC content is conserved during the ﬁrst
two decades of life [130,131]. So we let (t), the number of TRECS per naive
CD4+ T cell, be constant with mean 0.08 0:01 (s.e.m.).
Although it is assumed that there exists no signiﬁcant change in  with age,
there is considerable variation between individuals so  is ﬁtted to a linear de-
cay and the 95% conﬁdence interval of the slope, or equivalently _ (t), is found
to be (-1.7x 10 5, 2x10 6).
The assumption that _ (t) 0 is justiﬁed by considering that minimal Ki67 ex-
pression within the naive CD4+ T cell population occurs at age 20 and is of the
order0.2%, thisiscombinedwithestimatesfor ( 0:5, ref[66]), and ( 0:08,
ref [1]) to numerically approximate Min[y(t) =]  3x10 4. Max[_ (t)] is esti-3.5 Appendices 77
mated from the 95% conﬁdence interval as described above to be of the order
1.7x10 5, so _ (t) is approximately 20-fold smaller than the ﬁrst term, y(t)=,
in equation (3.14). This difference is even more pronounced in younger chil-
dren where up to 2% of naive cells are dividing at any given time, and _ (t) is
greater than 100-fold smaller than the ﬁrst term, hence the _ (t)term is ignored
and equation (3.14) becomes
(t) =
y(t) N(t) 
 (c   )
: (3.15)
In Figure 3.5 thymic export is estimated assuming that TREC frequency in the
naive CD4+ T cell pool declines continuously, from approximately 0.1 at birth
to 0.001 at age 80, and is found to be comparable to our original results where
it was assumed that the naive TREC frequency was constant to age 20 and
equal to 0.08. The 100 fold decrease in naive TREC frequency over 80 years
corresponds to a rate of change in  per day of 3 x10 6 using the same argument
as above this is 100 fold smaller than the ﬁrst term in equation (3.14) and the
difference between the two estimates is largely due to the different values for
frequency of TRECs per naive cell, .
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Figure 3.5: Thymic export calculated under the assumption that frequency of
TRECs per naive CD4+ T cell decline continuously from approximately 0.1 at birth
to 0.001 at age 80 (dashed line), compared to thymic export calculated assuming
the value of TRECs per naive cell is 0.08 and remains constant until age 20 (solid
line).3.5 Appendices 78
3.5.3 Alternative modelling approach to estimate contribution
of peripheral cell division
Smith and Martin [146] proposed a model of cell cycle divided into two phases;
a stochastic A-phase of variable length, representing the G1 stage of cell cycle,
followed by a more deterministic B-phase including the S, G2 and M stages
of cycle. Ki67 is a cell cycle marker that is expressed from late stage G1 and
is rapidly degraded post mitosis [144,145], and hence provides a fairly good
measure of the number of cells in B-phase. This model is adapted to interpret
Ki67 expression within the naive CD4+ T cell population.
It is estimated that cells take B days to complete B-phase, where time taken
is assumed to be relatively conserved, irrespective of cell type or age. Gett and
Hodgkin [66] determined the average division time for a naive CD4+ T cell to
be 12.4 (1:0 hours).
It is assumed that resting cells (Ki67  ) in an individual of age t transition into
B-phase at a rate a(t). This is modelled as an exponential processes, and so
1=a(t) isapproximatelytheexpectedtimetoentrytoB-phaseforagivenresting
(Ki67-) naive CD4+ T cell. Deﬁne S(t) to be the number of naive cells produced
through cell division in the periphery each day. Cells produced between time t
and t 1 must enter the B phase of cycle between t 1 B and t B, where
time is measured in units of days:
S(t) =
Z t B
t B 1
N(i)a(i)e
 B di; (3.16)
where a cell takes B days to complete B-phase, N(i) is the size of the total
naive cell population, and a(i) is deﬁned previously. At any point in time, i,
it is assumed that N(i)a(i) cells will enter the deterministic phase of cell cycle
and the probability of successfully survive B-phase and completing mitosis is
estimated to be exp( B), where  is the death rate of naive cells in cycle. It is
assumed that N(i) and a(i) do not change signiﬁcantly over the period of a few
days. Hence the function to be integrated becomes approximatelya constant3.5 Appendices 79
and the number of naive cells produced through division in the periphery each
day can be expressed as
S(t) = N(t)a(t)e
 B (3.17)
where N(t) and a(t), represent N(i) and a(i) for i 2 (t   B   1;t   B),
respectively.
Using the same approach a related expression can be derived for the number
of cells that express Ki67 at any given time, Y (t):
Y (t) =
Z t
t 
N(i)a(i)e
 (t i) di (3.18)
where  is the duration of Ki67 expression. As before it is assumed N(t) and
a(t) are constant over the period of a few days, and hence the number of naive
cells expressing Ki67 at any given time, t, can be described as follows:
Y (t) =
N(t)a(t)

 
1   e
 
(3.19)
In order to ﬁnd an expression for total cell production per day in terms of
Ki67 expression, the duration of Ki67 expression, , is estimated to be approx-
imately equal to the duration of B-phase, B, to give the following expression
for cell production per day from equations (3.17) and (3.19):
S(t) =
Y (t)
e   1

Y (t)
 +
2
2 + O
h
23
3!
i (3.20)
where  is the rate of loss of naive cells from cycle. There is currently no esti-
mate for this term from the experimental literature that we are aware of, how-
ever it is known to lie between 0 and 1. The last terms in the above expression
are ignored since they are at least ﬁfty fold smaller than ;   0:5 (days) and
 < 1 implies that 23=3! < =48.3.5 Appendices 80
Applying this deﬁnition of peripheral production to equation (3.4) gives:
(t) =
y(t) N(t) 
(e 1)
 (c   )

y(t) N(t) 
( +
2
2 ) (c   )
(3.21)
where dividing cells represent such a small proportion of the overall naive pool
that the rate of loss from this subpopulation, , may well be signiﬁcantly higher
than the average rate of loss from the bulk naive CD4+ T cell population. In
Figure 3.5 thymic export is calculated for the extreme values of  and it is
found that the predicted output is fairly robust to the value of . Using this
approach to model Ki67 expression gives comparable estimates for thymic ex-
port to the approach described previously in the methods (compare Figures 3.3
and 3.6).
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Figure 3.6: Mean thymic export estimated using an alternative modelling ap-
proach where  = 0 (solid line), 0.5 (dashed line), or 1 (dotted line) in equation
(3.21).
3.5.4 Modelling distribution of thymic export function
The distribution of total body naive cells, N(t), and TREC content per naive
cell, (t), is modelled elsewhere in appendix 2.5.1.
A simple exponential decay model, y(t) = aexp( ct) (t measured in years) is
used to describe the experimentally observed frequency of naive CD4 T cells
in blood that are Ki67+ as a function of age. R is used to determine the least-
square estimates of the model parameters. A distribution is constructed for
y(t) by considering the variation in the predicted parameters; a is assumed to3.5 Appendices 81
be normally distributed with mean 0.019 and variance 0.005, c has a mean of
0.099 (95% conﬁdence interval: (0.026, 0.271)) and is best ﬁt to a lognormal
distribution with parameters = -2.45 and = 0.56.
Average naive cell cycle duration, , is assumed to be normally distributed
with mean 0.52 days and variance 0.05 [66].
Thymic export (t) is a non-linear function of N(t), y(t), , and _ (t), and so a
Monte Carlo approach is used to construct an approximate, empirical distribu-
tion for (t).3.5 Appendices 82
Subject ID Age (years) % Naive CD4+ Ki67+ Data Source
B01 1 2.9 [2]
B02 2 2.7 [2]
B03 1 1.1 [2]
B04 1 0.8 [2]
B05 2 1.2 [2]
B06 2 4.2 [2]
B07 2 1.9 [2]
B08 3 1.0 [2]
B09 3 0.6 [2]
B10 3 0.3 [2]
B11 4 0.2 [2]
B12 6 0.5 [2]
B13 6 0.7 [2]
B14 6 0.0 [2]
B15 6 1.8 [2]
B16 7 1.2 [2]
B17 8 0.9 [2]
B18 9 0.3 [2]
B19 11 0.8 [2]
B20 12 0.2 [2]
B21 14 0.4 [2]
B22 14 0.1 [2]
B23 16 0.5 [2]
B24 22 0.1 [1]
B25 25 0.1 [1]
B26 25 0.1 [1]
B27 26 0.2 [1]
B28 27 0.2 [1]
B29 27 0.3 [1]
B30 27 0.4 [1]
B31 28 0.6 [1]
B32 29 0.7 [1]
B33 29 0.9 [1]
B34 67 0 [1]
B35 70 0.0 [1]
B36 72 0.0 [1]
B37 72 0.0 [1]
B38 73 0.0 [1]
B39 75 0.1 [1]
B40 76 0.2 [1]
B41 77 0.4 [1]
B42 79 0.4 [1]
B43 79 0.6 [1]
Table 3.1: Observed percentage of naive CD4+ T cells expressing Ki67 in healthy
individuals aged 0 to 70 years. Data from Hazenberg et al. [2] & Douek et al. [1])3.5 Appendices 83
Subject ID Age (years) TRECs per Naive CD4+ T cell
A1 0 0.096
A2 0 0.166
A3 0 0.091
A4 0 0.090
A5 6 0.066
A6 7 0.067
A7 8 0.035
A8 9 0.068
A9 10 0.106
A10 12 0.074
A11 13 0.123
A12 15 0.066
A13 17 0.036
A14 21 0.065
A15 25 0.051
A16 26 0.094
A17 26 0.072
A18 27 0.034
A19 30 0.027
A20 34 0.023
A21 34 0.030
A22 34 0.041
A23 40 0.025
A24 42 0.022
A25 43 0.027
A26 43 0.025
A27 50 0.006
A28 54 0
A29 55 0.004
A30 62 0.006
A31 62 0.007
A32 65 0.001
A33 73 0.003
A34 76 0.001
Table 3.2: Observed frequency of TRECs per naive CD4+ T cell in healthy individ-
uals aged 0 to 60 years. Data from Douek et al. [1]Chapter 4
Inter-cellular variation in the
residency time of PTK7+ naive
CD4+ T cellsAbstract
Protein tyrosine kinase 7 (PTK7) has been identiﬁed as a surrogate marker of
recent thymic emigration. The aim of this chapter is to explain the long-term
persistence of PTK7+ naive CD4+ T cells in thymectomised individuals and
explore the residency time of thymic emigrants within the PTK7+ state. It is
shown that incomplete thymectomy alone can not fully explain the residual
population of PTK7+ T cells and that the average rate of PTK7+ T cell loss
must decline following thymectomy. Inter-cellular variation in the time taken
to differentiate from PTK7+ to PTK7  T cells can explain the bi-phasic decline
in PTK7+ T cells following thymectomy. The mathematical model described
here predicts that a heavy-tailed distribution of PTK7 residency times, with an
expected duration of PTK7 expression of 23 days, would be required to ex-
plain the experimental observations. The implications of this model are: (a)
thymectomy preferentially depletes ’shorter-lived’ cells leading to an acceler-
ated increase in the average post-thymic age of remaining PTK7+ T cells fol-
lowing thymectomy; and (b) more-persistent ’veteran’ cells will preferentially
accumulate over a number of decades leading to an increase in the average
post-thymic age of PTK7+ T cells in older individuals. Suggesting that, despite
the immature phenotype, PTK7+ T cells do not necessarily represent a popu-
lation of recent thymic emigrants, particularly in thymectomised and elderly
subjects. These ﬁnding suggest that the impact of thymectomy may go beyond
the observed decline in cell numbers.4.1 Introduction 86
4.1 Introduction
The thymus plays an important role in maintaining T cell numbers and a di-
verse T cell receptor repertoire throughout the lifetime of an individual. In hu-
mans, recent thymic emigrants (RTEs) are commonly identiﬁed by cell surface
markers expressed on circulating T lymphocytes. CD31 (platelet endothelial
cell adhesion molecule-1, PECAM-1) and PTK7 (protein tyrosine kinase 7) are
two surrogate markers commonly used to identify naive CD4+ T cells in hu-
mansthathaverecentlyemigratedfromthethymus[3,55]. PTK7ismosthighly
expressed on least mature, double-negative (CD4 CD8 ), thymocytes and is
progressively lost as cells transition to the more mature single-positive (CD4+
CD8  or CD4  CD8+ ) stage of thymic development [3]. It is thought that circu-
lating PTK7+ CD31+ naive CD4+ T cells are immediate peripheral descendants
of single-positive thymocytes and are precursors of more established PTK7 
CD31+ naive CD4+ T cells. Thymic emigrants appear to ﬁrst lose expression
of PTK7 and then CD31 in an antigen-independent manner as part of the stan-
dard passage of T cells joining the peripheral population (Figure 4.1). This is
supported by the following observations: (a) the PTK7+ CD31+ subset is con-
tained within the peripheral CD31+ naive CD4+ population; and (b) the num-
ber of signal joint TCR gene excision circles (sjTRECs) (stable non-replicative
DNA products of intrathymic V(D)J recombination) [52] is approximately 2.5-
fold higher in PTK7+ than PTK7  naive CD4+ T cells but less frequent than in
single positive thymocytes.
The natural progression of naive CD4+ T cells entering the peripheral popu-
lation, from PTK7+ CD31+, through PTK7  CD31+ , to PTK7  CD31  naive T
cells, is poorly understood. In vitro, cytokine-induced division results in the
progressive loss of surface PTK7 expression [3] while preserving CD31 expres-
sion [141,142]; however, the signals that induce a shift in phenotype in vivo are
unknown and in particular there are few studies exploring the role of PTK7
within T cells. PTK7 has been more extensively studied for its role in gas-
trulation and neurulation [160]; it is a co-receptor in the non-canonical WNT
pathway and controls the transcription of genes important to tissue polarity,4.1 Introduction 87
cell adhesion and motility [161,162].
PTK7+ 
CD31+ 
PTK7+ 
CD31+ 
PTK7‐ 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DURATION OF PTK7 
EXPRESSION 
Figure 4.1: Post-thymic maturation of T cells entering the circulating naive CD4+
T cell population.
In this chapter the residency time of thymic emigrants within the peripheral
PTK7+ naive CD4+ T cell population is considered as this will determine how
well the marker can be applied as a correlate of thymic activity. It is not pos-
sible to directly measure, in vivo, the time that a T cell leaving the thymus will
spend in the PTK7+ naive CD4+ T cell state, instead our knowledge of this
process relies upon indirect observations of, for example, the fraction of circu-
lating PTK7+ naive CD4+ T cells that remain when de novo production ceases,
i.e. following thymectomy. Haines and colleagues observed that following an
initial drop, thymectomised subjects were able to maintain a stable residual
population of PTK7+ naive CD4+ T cells (so-called RTEs) for at least 6 months
post-thymectomy [3]. The aim of this study is to explain the long-term persis-
tence of PTK7+ naive CD4+ T cells in thymectomised individuals with a view
tobetterdeﬁningtheearlyPTK7+ stageofTcelldevelopmentandtoultimately
better understand how thymic emigrants are incorporated into the peripheral
naive T cell pool.4.2 Mathematical model 88
Theoretically, the persistence of PTK7+ naive CD4+ T cells might reﬂect: (a)
residual thymic production; (b) increased peripheral expansion of PTK7+ T
cells; and / or (c) increased persistence of peripheral PTK7+ T cells. Here a
mathematical approach is used to show that incomplete thymectomy alone is
unable to explain the residual PTK7+ naive CD4+ T cell population. It is not
clear how compensatory mechanisms might operate to maintain PTK7+ naive
CD4+ T cells in the absence of thymic production. Increased peripheral divi-
sion might explain the experimental observations, however, in vitro at least,
cytokine-induced division has been shown to result in the loss of PTK7 expres-
sion [3] suggesting that the extent to which division is capable of maintaining
immature PTK7+ naive CD4+ T cells might be limited. Here it is shown that
a heavy-tailed distribution of PTK7+ T cell residency times, ie. one where the
survivorship of cells within the PTK7+ state decays slower than exponentially,
can explain the persistent PTK7+ T cell population. A mathematical model is
used to explore the consequences of this inter-cellular variation in residency
times for the PTK7+ T cell population in thymectomised and aged individuals.
The ﬁndings suggest that, despite the immature phenotype, PTK7+ T cells do
notnecessarilyreﬂectrecentlyemigratedTcells, particularlyinthymectomised
and elderly subjects.
4.2 Mathematical model
A survival model is used to explore the residency time, or ’life expectancy’, of
thymic emigrants within the PTK7+ naive CD4+ T cell population and to inves-
tigate the homeostatic processes that sustain the T cell pool following thymec-
tomy. To study how long a cohort of thymic emigrants will persist in the circu-
lating PTK7+ naive CD4+ T cell population, we let the cumulative distribution
of residency times, Ft(x), represent the fraction of cells from a given cohort of
T cells leaving the thymus, in an individual aged t, that will remain in the cir-
culating PTK7+ naive CD4+ T cell population x days post-export. Ft(x) can
be described as a survivorship function and represents the fraction of PTK7+
naive CD4+ T cells that are not lost to differentiation, death, or migration out4.2 Mathematical model 89
of the peripheral PTK7+ compartment. Studies have shown that the loss of re-
cently produced naive CD4+ T cells through cell death or migration out of the
peripheral system is negligible over labelling periods of up to 200 days [62,64],
suggesting that the loss of PTK7+ naive CD4+ T cells, at least during the ﬁrst
6 months after thymic export, will be almost exclusively associated with post-
thymic maturation into the PTK7  naive T cell population.
Under normal physiological conditions, the frequency of PTK7+ naive CD4+ T
cells in an individual aged t, X(t), is determined by a convolution of thymic
output and the survivorship of those emigrants within the circulating PTK7+
naive CD4+ T cell population, as follows:
X(t) =
Z t
0
(a)Fa(t   a)da: (4.1)
Where, (a) is the rate at which PTK7+ naive CD4+ T cells are exported by the
thymus (cells/day), in an individual aged a; Fa(x) is the fraction of thymic em-
igrants that is predicted to persist in the peripheral PTK7+ naive CD4+ T cell
population x days, in an individual aged a. (All units of time and age are mea-
sured in days.) In the interests of simplicity it is assumed that division within
the PTK7+ subpopulation is negligible. This assumption is justiﬁed by the ob-
served loss of PTK7 expression on naive cells following division in vitro [3].
In appendix 4.5.1 the model is extended to include a constant rate of division
within the PTK7+ T cell pool and it is shown that the results that follow are
robust to this background division.
Modelling thymectomy
The general survival model is adapted to describe the natural decline of PTK7+
naive CD4+ T cells following thymectomy, in the absence of compensatory
mechanisms such as increased proliferation or decreased cell loss. The size
of the PTK7+ naive CD4+ T cell population, X(t), following thymectomy at
age t0, can be described by allowing normal thymic production to age t0 but
considering the fraction of cells that persist to some time of observation (t > t0)4.2 Mathematical model 90
post-thymectomy, as follows:
X
(t) =
Z t0
0
(a)Fa(t   a)da +
Z t
t0
p(a)Fa(t   a)da (4.2)
where p represents the fraction of residual thymic production that continues
post-thymectomy (0  p < 1). At this stage no assumptions are made about
the functional form of the survivorship function (Fa(t)). A simple exponen-
tially decay would imply a constant rate of transition from PTK7+ to PTK7 
naive CD4+ T cells, while divergence from the simple exponential survivor-
ship function would suggest that there exists some variation in the rate of tran-
sition.
Variation model
The variation model describes a scenario where the persistence of PTK7+ naive
CD4+ T cells following thymectomy is a natural consequence of the normal
variation in the rate at which cells transition from PTK7+ to PTK7 . A math-
ematical model can be used to estimate the underlying survivorship function
required to describe the clinical observations under the variation model as fol-
lows.
Equation (4.2) can be rewritten to compare the number of PTK7+ naive CD4+ T
cells in a healthy individual aged t, X(t), to the expected number of PTK7+
naive CD4+ T cells in an individual that undergoes thymectomy at age t0,
X(t), where t  t0, as follows:
X
(t) = X(t)  
Z t
t0
(1   p)(a)Fa(t   a)da: (4.3)
According to the variation model, the frequency of PTK7+ T cells post-
thymectomy is simply equivalent to the size of the population in a non-4.2 Mathematical model 91
thymectomised, aged-matched individual less the cells that would have been
produced from time t0 to a later observation time, t. In order to extract
the survivorship function, Fa(x), that is required to explain observed PTK7+
T cells post-thymectomy, consider the rate of change of cell numbers post-
thymectomy:
dX(t)
dt
=
dX(t)
dt
  lim
t!0
R t+t
t0 (1   p)(a)Fa(t + t   a)da  
R t
t0(1   p)(a)Fa(t   a)da
t
(4.4)
where dX(t)=dt  0, since the observed change in PTK7+ naive CD4+ T cell
numbers is negligible in non-thymectomised children over a 6 month period
[3], and a change of variables, a = a0 + t, can be used to rewrite the ﬁrst
integral, as follows:
dX(t)
dt
  (1   p) lim
t!0
R t
t0 t (a0 + t)Fa0+t(t   a0)da0  
R t
t0 (a)Fa(t   a)da
t
:
(4.5)
Equation (4.5) can be simpliﬁed by assuming: (a) (a0 + t)  (a0), it is
reasoned that thymic production diminishes over a number of decades and
hence the change over some small period t is likely to be neglible; and (b)
Fa0+t(t   a0)  Fa0(t   a0), where the survivorship function of PTK7+ T cells is
not likely to be signiﬁcantly different for cohorts of thymic emigrants leaving
the thymus t days apart. The equation becomes:
dX(t)
dt
  (1   p) lim
t!0
R t0
t0 t (a)Fa(t   a)da
t
  (1   p)(t0)Ft0(t   t0) (4.6)
Since all T cells leaving the thymus are assumed to enter the PTK7+ population
at day 0, the boundary condition is Ft0(0) = 1 and the equation becomes:4.3 Results 92
(t0)   
1
1   p
dX(t0)
dt
: (4.7)
Hence, we obtain the following expression for survivorship function:
Ft0 (i) 
1
dX(t0)
dt
dX (i days post thymectomy )
dt
: (4.8)
Using this expression, we can infer the underlying distribution of residency
times of peripheral PTK7+ naive CD4+ T cells leaving the thymus at age t0
using the observed rate of change in PTK7+ naive CD4+ T cell numbers post-
thymectomy.
4.3 Results
Residual thymic output is not sufﬁcient to explain the residual
PTK7+ naive CD4+ T cell population post-thymectomy
First, it is investigated whether residual thymic output alone is able to explain
the long term presence of PTK7+ naive CD4+ T cells following thymectomy, in
theabsenceofinter-cellularvariationinPTK7residencytimesorcompensatory
mechanisms such as a density-dependent rates of cell loss and / or prolifera-
tion. In order to do this, the most general survival model is used to consider the
post-thymectomy dynamics in the absence compensatory mechanisms (equa-
tion (4.2)). The inﬂuence of inter-cellular variation is removed by assuming a
constant rate of transition from PTK7+ to PTK7  T cells, of  > 0, such that the
survivorship function becomes a simple exponential decay (Fa(t) = exp[ t]).
Equation (4.2) describes the frequency of PTK7+ naive CD4+ T cells following
thymectomy and can be re-written as follows:4.3 Results 93
X
(t) = (1   p)
Z t0
0
(a)Fa(t   a)da + p
Z t
0
(a)Fa(t   a)da
= (1   p)
Z t0
0
(a)exp[ (t   a)]da + p
Z t
0
(a)exp[ (t   a)]da
= Aexp[ t] + pX(t) (4.9)
! pX(t) as t ! 1:
where A = (1 p)
R t0
0 (a)exp[a]da, is constant with respect to t. It can be seen
that under this simple model, PTK7+ T cell numbers will exponentially drop
to pX(t), where p represents the fraction of thymic production that continues
after thymectomy and X(t) represents the expected number of PTK7+ T cells
in a normal, non-thymectomised individual of the same age. In Figure 4.2, the
incomplete thymectomy model alone is used to predict the change in PTK7+
naive CD4+ T cells post-thymectomy for varying fractions of residual thymic
production, p. In the absence of inter-cellular variation in residency times or
compensatory mechanisms in response to thymectomy, residual thymic output
of the order of 15% and 45% is required to explain experimental observa-
tions made by Haines et al. [3] in children thymectomised at age 2 and 14 years,
respectively (Figure 4.2 B & C).
Although complete thymectomy is unlikely to be 100% efﬁcient, the anal-
ysis presented here suggests that residual thymic production alone would
not be sufﬁcient to explain the observed residual PTK7+ population post-
thymectomy. Haines and colleagues [3] followed the progress of subjects with
myasthenia gravis where thymectomy was described as clinically complete.
Typically, short-term completion studies in patients who have undergone com-
plete thymectomy for treatment of myasthenia gravis reveal <5% residual
thymic tissue [163]. Alternative sources of thymic production could include ec-
topic thymi. For example, Terszowski and colleagues [164] presented evidence
for a functional second thymus in the mouse neck. Although the structure of
both, chest and neck, thymi were found to be similar, a thymic lobe in the neck4.3 Results 94
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Figure 4.2: Simulating PTK7+ naive CD4+ T cells post-thymectomy for vary-
ing fractions of residual thymic production, p, in the absence of compensatory
division or varying rates of cell loss due either to density-dependent survival
or heterogeneity in the residency times. A: Array of feasible exponential PTK7
survivorship functions (corresponding to a constant exponential rate of transition
from PTK7+ to PTK7  naive T cells.); B & C: Simulated post-thymectomy dynam-
ics in a typical 2 and 14 year old, reconstructed using equation (4.9) where the
fraction of residual thymic production is set to be 0, 0.1, 0.2 and 0.45, and each
curve corresponds to a survivorship function identiﬁed in 4.2A. Estimates for me-
dian thymic export are as determined in chapter 3. Actual observations by Haines
& colleagues [3] (ﬁlled circles).4.3 Results 95
was found to carry  1:6105 thymocytes compared to  1108 in the thoracic
thymus. Additionally, the thoracic thymus was observed to be multi-lobulated,
whereas the neck thymus appeared single lobed and at most 3 ectopic thymic
organs were observed. If it is assumed that thymic output is comparable to the
number of thymocytes, this suggests that the relative contribution of secondary
thymic tissue is at least 100-fold smaller than the primary thoracic thymus. In
combination, theseobservationssuggestthatresidualthymicproductionmight
realistically be of the order of less than 5% which is somewhat less than the
15-45% required to explain the experimental observations.
The average per-cell rate of loss of PTK7+ naive CD4+ T cells
declines with increasing time post-thymectomy
Since incomplete thymectomy alone is unable to explain the long term persis-
tence of PTK7+ naive CD4+ T cells following thymectomy, the role of extended
PTK7+ naive CD4+ T cell persistence is considered. A simple ordinary dif-
ferential equation model is used to show that the average rate at which cells
transition from PTK7+ to PTK7  naive CD4+ T cells must decline after thymec-
tomy. If thymectomy is assumed to be complete, then the following expression
determines the size of the PTK7+ naive CD4+ T cell population, X(t), after
thymectomy:
dX(t)
dt
=  (t)X
(t) (4.10)
where (t) is the average per-cell rate of loss of cells from the PTK7+ naive
CD4+ T cell population, at time t after thymectomy. Clinical observations sug-
gest that the PTK7+ T cell population, X(t), approaches a new (non zero)
set point following thymectomy [3], hence (t) must approach zero with af-
ter thymectomy to explain the decline in net change in PTK7+ T cells per day
(
dX(t)
dt ) to zero [3].
There are at least two distinct ways in which a decline in the average rate of
loss can be explained. One possibility is a model in which the rate of transi-4.3 Results 96
tion, from PTK7+ to PTK7  naive T cells, declines homogeneously across the
entire PTK7+ pool with time, perhaps as a function of population size. Density-
dependent growth and survival are commonly applied in ecological models to
explain the maintenance of population numbers and are typically thought to
arise from some form of competition for limited resources or predation. In this
situation loss of PTK7+ naive CD4+ T cells is thought to predominantly involve
transition from the less mature PTK7+ to more established PTK7  T cell pool
and the mechanisms that might lead to a density-dependent length of stay in
immature PTK7+ stage of the T cell lifecycle are not at all clear. A density-
dependent rate of transition would suggest that PTK7+ T cells require some
stimuli to remain in the PTK7+ state, ie. differentiation from PTK7+ to PTK7  is
driven by the loss of some signal, perhaps related to IL-7 availability. At lower
cell densities there would be plenty of the required stimuli resulting in a lower
rate of PTK7+ T cell loss, while more cells would result in more competition for
the stimuli and an increase in the rate of PTK7+ T cell loss. If the opposite was
true, ie. differentiation from PTK7+ to PTK7  was positively driven by some
maturation signal, then at lower cell densities there would be potentially fewer
PTK7+ T cells competing for such stimuli leading to an increase in the rate of
transition, which is the opposite of the required relationship between PTK7+ T
cell density and loss.
An alternative to this homogeneity model, is a variation model where there
exists natural inter-cellular variation in PTK7+ naive CD4+ T cell residency
times. Here, the initial decline in PTK7+ T cells following thymectomy would
reﬂect the loss of intrinsically ”shorter-lived” cells that rapidly transition into
the PTK7  T cell compartment immediately after export, while the second
relatively stable phase of thymectomy reﬂects the behaviour of the naturally
”more-persistent” cells.
In the work that follows, the distribution of residency times that is required
to ﬁt the variation model is estimated and the consequences of such a distri-
bution for the natural aging process are examined. Although both models can
explain the clinical changes in PTK7+ naive T cell numbers, it is shown that4.3 Results 97
inter-cellular variation has some serious implications for the post-thymic age
of residual PTK7+ T cells in thymectomised individuals.
Expected residency time of PTK7+ naive CD4+ T cells  23.3
days.
As the number of observations following thymectomy are fairly limited [3],
measurement error of  20 cells/l is allowed for and an array of standard bi-
exponential curves is used to deﬁne the feasible observation space (Figure 4.3A
& B). A method for estimating the distribution of residency times (or equiv-
alently survivorship function) that is required to describe a given decline in
PTK7+ naive CD4+ T cells under the variation model is derived in equation
(4.8). In Figure 4.3C, the survivorship functions that correspond to the biexpo-
nential curve within the feasible space are explored.
It is assumed that a per-cell rate of loss of 1(/day) gives a reasonable upper
bound on the rate of transition from PTK7+ to PTK7  naive T cells. This limit
determines an upper bound on the decay of PTK7+ naive CD4+ T cells post-
thymectomy and a minimal survivorship function for thymic emigrants within
the PTK7 compartment (red lines in Figure 4.3A, B & C).
The maximal survivorship function is identiﬁed by the feasible decay of PTK7+
T cells post-thymectomy that corresponds to the maximal survivorship to day
250 (Max[Fa(250 days)]), since experimental observations only extend to 250
days post-thymectomy (blue line in Figure 4.3A & B). The maximal survivor-
shipfunctioncorrespondstothepersistenceofapproximately 0.4%ofthymic
emigrants within the PTK7+ compartment 250 days after export in 2 year old,
and  12% at age 14 years (Figure 4.3C).
The model assumes that the survival of PTK7+ naive CD4+ T cells post-
thymectomy reﬂects the normal physiological behaviour of cells in the absence
of compensatory mechanisms. In the presence of additional production or ex-
tended PTK7 lifespans in response to thymectomy, the model will overstate the
’normal’ persistence of PTK7+ naive CD4+ T cells and hence this upper bound4.3 Results 98
is a conservative limit on PTK7 persistence and is robust to different models of
post-thymectomy dynamics.
The feasible survivorship functions identiﬁed in Figure 4.3C are validated us-
ing observations of PTK7+ naive CD4+ T cells in healthy, non-thymectomised
individuals of different ages, as measured by Haines et al. [3]. According to the
simple survival model deﬁned previously, the frequency of circulating PTK7+
naive CD4+ T cells with age is simply a convolution of thymic production and
the survivorship of PTK7+ naive CD4+ T cells (equation (4.1)). It is assumed,
parsimoniously, that survivorship of thymic emigrants within the PTK7+ naive
CD4+ T cell compartment is independent of the age of host at time of export.
Quantitative estimates of daily thymic export, derived in chapter 3, are com-
bined with the feasible survivorship functions to reconstruct the change in cir-
culating PTK7+ naive CD4+ T cell numbers with age (Figure 4.3D). The model
simulations are able to capture the observed change in PTK7+ naive CD4+ T
cell numbers with age [3].
Finally, a least-square optimisation is used to identify the survivorship function
thatlieswithinthelimitsdeterminedbydatafromthymectomisedpatientsand
best describes the change in PTK7+ naive CD4+ T cell numbers in healthy indi-
viduals with age (Table 4.1). The derived function corresponds to an expected
residency time of  23.3 days within the PTK7+ naive CD4+ T cell population
(solid black curve in Figure 4.3C). This reﬂects a situation where 95% of thymic
emigrants will transit through the PTK7+ stage within 25 days, although the
key to explaining the persistence of PTK7+ T cells post-thymectomy is that the
distributionisinherentlyheavy-tailedand0.4%ofcellswillpersistforgreater
than a year. Biologically, this might reﬂect a progressive decline in the expres-
sion of co-stimulatory or signalling molecules with increasing time spent in
the periphery that reduces the probability a PTK7+ T cell will mature into the
PTK7  naive pool. Alternatively, the long-lived fraction of PTK7+ naive CD4+
T cells may represent a subpopulation of cells that are intrinsically less respon-
sive to maturation stimuli from time of export, perhaps related to heterogeneity
in T cell receptor speciﬁcity.4.3 Results 99
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Figure 4.3: A,B: Feasible decline in PTK7+ naive CD4+ T cells post-thymectomy is
limited by clinical observations by Haines & colleagues [3] (ﬁlled circles) and mea-
surement error of  20 cells /l (black lines) in individuals aged 2 and 14, respec-
tively; C: Feasible PTK7 survivorship functions corresponding to observed decay
of PTK7+ naive CD4+ T cells; D: PTK7+ naive CD4+ T cell numbers observed in
non-thymectomised, healthy individuals (ﬁlled circles) by Haines & colleagues [3]
compared to PTK7+ naive CD4+ T cell numbers simulated using equation (4.1)
in combination with independent estimates of thymic export (chapter 3) and fea-
sible survivorship functions. Solid black line represents the simulation that best
describes the observations in healthy individuals and corresponds to the survivor-
ship function (black line) in Figure 4.3C.4.3 Results 100
Subject ID Age PTK7+ Naive CD4+ T cells
(years) (cells/l)
C01 2 317
C02 5 180
C03 5 156
C04 5 128
C05 4 64.
C06 14 160
C07 14 44
C08 16 27
C09 25 28
C10 27 67
C11 27 5
C12 31 22
C13 32 0
C14 33 7
C15 38 37
C16 52 2
Table 4.1: Observed frequency of PTK7+ naive CD4+ T cells (cells/l) in healthy
individuals aged 0 to 60 years. Data from Haines et al. [3]
PTK7+ naive CD4+ T cells do not necessarily represent recently
emigrated cells
Inthissection, theimplicationsofaheavy-taileddistributionofresidencytimes
combined with cumulative thymic export over the lifespan of an individual are
explored. The survivorship function that is best able to reproduce quantitative
changes in PTK7+ naive CD4+ T cell numbers with age (Figure 4.3C) is used
together with the model to reconstruct the PTK7+ T cell population and track
the fate of cells according to their post-thymic age (described in more detail in
Appendix 4.5.1). In agreement with observed cell concentrations in peripheral
blood [3], the model predicts that total body numbers of PTK7+ naive CD4+ T
cells decline continuously from a peak at age 1 (Figure 4.4A).
The number of ’most recent’ thymic emigrants, ie. the number of PTK7+ naive
CD4+ T cells that have spent less than 3 months in the periphery, appear to
peak at age 1 years and then decline in a bi-phasic manner to age 60 years,
in line with diminishing thymic export (see Figure 3.4C). In contrast, the total
number of veteran PTK7+ naive CD4+ T cells (deﬁned as cells that have spent4.3 Results 101
more than a year in the periphery) increases to age 8 years and then declines
15-fold to age 60 (Figure 4.4A). As a result, the veteran cells represent an
increasinglydominantfractionofthePTK7+ naiveCD4+ Tcellpopulationwith
age. The percentage of veteran cells is predicted to increase from 25% at age
2 years to 85% at age 60 years. As a consequence, the average post-thymic
age of peripheral PTK7+ naive CD4+ T cells is predicted to increase almost
linearly from approximately 0 at birth to 21 years at age 60; the average post-
thymic age of a PTK7+ naive CD4+ T cells in a young adult is predicted to
be 6.5years (Figure 4.4C). The dramatic increase in the average post-thymic
age of cells with aging described here occurs in the absence of any change in
the residency time of newly-exported emigrants or change in environmental
stimuli and is a direct result of the preferential accumulation of ’long-lived’
cells from within each cohort of thymic emigrants. In appendix Figure 4.8 an
alternative lognormal distribution is used to describe the change in PTK7+ T
cell numbers and it is found that the increase in post-thymic age is robust to
the heavy-tailed distribution chosen to ﬁt the data.
Transition from the PTK7+ to the PTK7  naive compartment is
almost exclusively associated with the most-recently emigrated
T cells
The average rate at which cells leave the PTK7+ naive CD4+ T cell population
is estimated as follows:
(t) =
R t
0 (a)fa(t   a)da
X(t)
(4.11)
where fa(x) represents the fraction of cells exported at age a that will be lost
from the PTK7+ population on day x post-export, such that Fa(t) =
R t
0 fa(x)dx;
and X(t) is the size of the PTK7+ naive CD4+ T cell population at age t, as
before. The expected distribution of PTK7 residency times identiﬁed in Fig-
ure 4.3C predicts that in accord with the increase in average time spent in the
periphery (Figure 4.4C), the average rate of conversion from PTK7+ to PTK7 4.3 Results 102
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Figure 4.4: Implications of a heavy-tailed distribution of PTK7+ naive CD4+ T
cell residency times for natural aging. Predicted peripheral PTK7+ naive CD4+ T
cells, intermsoftotalcellnumbers(A)andpercentageofcells(B)withineachpost-
thymic age category, is simulated using the best-ﬁt PTK7+ naive CD4+ T cell sur-
vivorship function (described in Figure 4.3C) and quantitative estimates of daily
thymic export (described in Figure 3.4). C: Average post-thymic age of peripheral
PTK7+ naive CD4+ T cells as a function of age; D: Predicted per-cell rate of tran-
sition and post-thymic age of PTK7+ T cells lost to PTK7  naive T cell population.4.3 Results 103
drops 6-fold from 10% to 1.6% of PTK7+ T cells per day from age 1 to 60
years (Figure 4.4D).
The post-thymic age of cells lost from the PTK7+ naive CD4+ T cell pool was
also calculated. Despite the dramatic shift in the post-thymic age of PTK7+
naive CD4+ T cells in aging individuals (Figure 4.4B), the post-thymic age of
cells transitioning from the PTK7+ to PTK7  pool appears to be independent
of age, that is, greater than 99% of cells leaving the PTK7+ naive CD4+ T cell
compartment are predicted to have spent less than 1 month in the periphery,
even in a 60 year old individual (Figure 4.4D).
Thymectomy results in an accelerated increase in the average
post-thymic age of PTK7+ naive CD4+ T cells
Thymectomy is simulated in typical individuals aged 2 and 14 years accord-
ing to the variation model (equation 4.2), allowing conservatively for the per-
sistence of 5% of original thymic production (Figure 4.5A & B). In appendix
Figure 4.9 it is shown that the post-thymectomy dynamics are fairly robust to
estimates of residual thymic production varying from 0 to 20%. The model al-
lows us to investigate the implications of thymectomy, combined with natural
variation in residency times, on the composition of the residual PTK7+ naive
CD4+ T cell population in a way that is difﬁcult to observe experimentally. The
best-ﬁt distribution of PTK7+ residency times suggests that the majority of cells
will transition into the more mature population within weeks of export. This
transitional component of the PTK7+ population will be rapidly depleted as
it fails to be replaced by de novo production of T cells by the thymus while a
fraction of veteran PTK7+ T cells will continue to persist.
In a non-thymectomised 2 year old, the most-recently emigrated T cells com-
prise 70% of the PTK7+ compartment and since the model predicts that
these cells are preferentially depleted following thymectomy, the average post-
thymic age of PTK7+ naive CD4+ T cells increases 3-fold within 2 months of
thymectomy. A similar process occurs in a 14 year old and the average post-4.3 Results 104
thymic age of PTK7+ naive CD4+ T cells is estimated to increase from 6.3 to
8.3 years within 2 months of thymectomy mirroring an accelerated form of
the increase in post-thymic age of cells that is predicted to coincide with nat-
ural aging. The variation model suggests that simply observing the change in
T cell numbers, even within individual T cell subsets, may underestimate the
impact of thymectomy. The post-thymic age of PTK7+ naive CD4+ T cells in
thymectomised children appears to more closely resemble that of older indi-
viduals than healthy, age-matched controls.
Thisisincontrastto the predictionsofthehomogeneitymodel, wheretheprob-
ability of transition, from PTK7+ to PTK7  naive T cells, is homogeneous across
the entire PTK7+ population. In Figure 4.6, the homogeneity model is used to
describe the post-thymectomy dynamics simulated in Figure 4.5. Using equa-
tion 4.10, the average rate of PTK7+ naive CD4+ T cell loss is predicted to de-
cline rapidly following thymectomy (Figure 4.6A & B). Unlike the variation
model however, this model predicts that all cells are lost at the same rate and
a preferential loss of most-recently emigrated cells post-thymectomy is not ob-
served. In Figure 4.6C & D the post-thymic age of cells is assumed to be iden-
tical to that simulated under the variation model until time of thymectomy,
allowing the way in which thymectomy differs under the two alternative mod-
els to be highlighted. Following thymectomy in the homogeneous model, the
only observed change in the composition of the residual PTK7+ naive CD4+
T cell population arises from the natural aging of cells. As a result, the ho-
mogeneity model predicts a slower linear increase in average post-thymic of
PTK7+ naive CD4+ T cells, that is quite distinct from the sudden jump in aver-
age post-thymic age that is predicted by the variation model.4.3 Results 105
Age 2 A
0 50 100 150 200 250
0
5.´109
1.´1010
1.5´1010
Days Post Thymectomy
P
T
K
7
+
n
a
i
v
e
T
c
e
l
l
s
Age 14 B
0 50 100 150 200 250
0
5.´109
1.´1010
1.5´1010
Days Post Thymectomy
P
T
K
7
+
n
a
i
v
e
T
c
e
l
l
s
C
0 50 100 150 200 250
0
2
4
6
8
10
Days Post Thymectomy
A
v
e
p
o
s
t
-
t
h
y
m
i
c
a
g
e
o
f
P
T
K
7
+
C
D
4
+
n
a
i
v
e
T
c
e
l
l
s
H
y
e
a
r
s
L D
0 50 100 150 200 250
0
2
4
6
8
10
Days Post Thymectomy
A
v
e
p
o
s
t
-
t
h
y
m
i
c
a
g
e
o
f
P
T
K
7
+
C
D
4
+
n
a
i
v
e
T
c
e
l
l
s
H
y
e
a
r
s
L
E
0 10 20 30 40 50 60
0
20
40
60
80
100
Age at time of thymectomy
R
e
s
i
d
u
a
l
P
T
K
7
+
n
a
i
v
e
T
c
e
l
l
s
H
%
o
f
n
o
r
m
a
l
a
g
e
-
m
a
t
c
h
e
d
c
e
l
l
c
o
u
n
t
L
0 1 3 6 12 24 60 120 180 240
Post-thymic age HmonthsL
Figure 4.5: Predicted implications of thymectomy on the post-thymic age of
PTK7+ naive CD4+ T cells when there exists inter-cellular variation in the rate
of transition, from PTK7+ to PTK7  naive CD4+ T cells. A & B: Absolute decline
in total number and post-thymic age of PTK7+ naive CD4+ T cells; C & D: Average
post-thymic age of the persistent PTK7+ naive CD4+ T cell population following
thymectomy in a typical 2 and 14 year old, respectively; E: Predicted size of persis-
tent PTK7+ naive CD4+ T cell pool following thymectomy at different ages, as a
percentage of expected cell numbers in age-matched non-thymectomised individ-
uals.4.3 Results 106
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Figure 4.6: Predicted implications of thymectomy on the post-thymic age of
PTK7+ naive CD4+ T cells when rate of transition, from PTK7+ to PTK7  naive
CD4+ T cells, is homogeneous across PTK7+ naive CD4+ T cell population. A
& B: Average per-cell rate of transition from PTK7+ to PTK7  naive CD4+ T cells;
C & D: Decline in total number and post-thymic age of PTK7+ naive CD4+ T cells;
E & F: Average post-thymic age of residual PTK7+ naive CD4+ T cell population
following thymectomy in a typical 2 and 14 year old, respectively4.3 Results 107
Variation in residency times naturally explains the persistence
of a larger population of PTK7+ naive CD4+ T cells following
thymectomy in older individuals through the accumulation of
persistent veteran PTK7+ T cells with age
The experimental data shows and the model predicts that PTK7+ naive CD4+
T cell numbers approach a quasi-set point within 250 days of thymectomy. The
size of the PTK7+ naive CD4+ T cell pool at day 250 post-thymectomy was
estimated and used to explore the new set point that would be reached fol-
lowing thymectomy in individuals of different ages under the variation model.
This provides a testable prediction of our hypothesis where data from addi-
tional patients could be used to verify the model. As before thymectomy was
simulated in typical individuals aged 0 to 60 years by assuming that residual
thymic production would be equivalent to 5% of original output. As expected,
the number PTK7+ T cells on day 250 after thymectomy, as a fraction of ex-
pected cell numbers in healthy, age-matched controls, increases continuously
with age. The steepest increase was observed from birth to age 10 years. Ap-
proximately 15% of PTK7+ naive CD4+ T cells are expected to persist following
thymectomy at age 1 compared to 70% by age 10 years. Persistence of PTK7+
naive CD4+ T cells to day 250 does not increase much from age 10 to 60 years
(from 70% to 82%). This compares to the observed persistence of 15% and
45% of PTK7+ naive CD4+ T cells in thymectomised subjects aged 2 and 14
years, respectively [3].
It is not intuitively obvious that thymectomy in early childhood should result
in a smaller long-lived residual PTK7+ naive CD4+ T cell population given
that the ’starting’ population is largest in these same individuals. The varia-
tion model predicts, however, that the PTK7+ naive CD4+ T cell population
in younger individuals predominantly consists of transitional cells with a high
rate of conversion into the PTK7  naive CD4+ T cell pool that are rapidly lost
following the suppression of thymic output. With age, the model predicts the
accumulation of more persistent cells and hence a smaller drop in PTK7+ naive4.4 Discussion 108
CD4+ T cell numbers following thymectomy.
4.4 Discussion
The immune system as a whole is fairly resilient to thymectomy. Sempowski
and colleagues [112] showed that the concentration of naive CD4+ T cells did
not fall signiﬁcantly following treatment of myasthenia gravis by thymectomy
and the concentration of memory CD4+ T cells was actually observed to in-
crease. The response of the naive T cell population to a drop in thymic output
is likely to represent a complex product of a change in cell survival, prolifera-
tion, differentiation and death. In this chapter, the changes that occur within
the more-recently emigrated PTK7+ naive CD4+ T cell subset are explored. The
kinetics are easier to interpret as compared to the naive T cell population since
it is thought that both proliferation and differentiation lead to the loss of cells
from the PTK7+ naive CD4+ T cell subset. Haines and colleagues [3] observed
that, following an initial drop in cell numbers, subjects were able to maintain
a fairly stable residual population of PTK7+ naive CD4+ T cells for up to 6
months post-thymectomy. In this work, the underlying homeostatic mecha-
nisms that might explain the post-thymectomy kinetics were explored.
It was argued that incomplete thymectomy alone is unable to account for the
persistent fraction of PTK7+ naive CD4+ T cells post-thymectomy (Figure 4.2).
Instead it was shown that the average rate at which cells are lost from the
PTK7+ naive CD4+ T cell population must decline post-thymectomy.
One possible explanation for the increased persistence of PTK7+ naive CD4+
T cells might be a time dependent rate of transition, from PTK7+ to PTK7 
naive CD4+ T cells, that is assumed to be homogeneous across the population
but declines in response to thymectomy. This might reﬂect a system where
the persistence of PTK7+ T cells is related to the size of the PTK7+ pool. For
example, if persistence of PTK7 expression on naive T cells was dependent on
some resource, perhaps cytokine stimulation, then competetion for this stimuli
would lead to a low rate of PTK7+ T cell loss when PTK7+ T cell densities were4.4 Discussion 109
low and vice-versa.
Alternatively, as proposed here, natural inter-cellular variation in the rate of
transition could also explain the residual population. Under this hypothe-
sis, the residual PTK7+ population is explained by the endurance of naturally
more-persistent, veteran, PTK7+ naive CD4+ T cells. The bi-phasic decline in
PTK7+ naive CD4+ T cells is an outcome of pre-existing heterogeneity and the
decline in average per-cell rate of transition simply reﬂects the preferential loss
of PTK7+ T cells with intrinsically shorter residency times.
Both models can explain the long term survival of PTK7+ naive CD4+ T cells
post-thymectomy. The mathematical analysis described here, however, identi-
ﬁes that the two models have signiﬁcantly different implications for our under-
standingoftheconsequencesofthymectomyandaging. Theinter-cellularvari-
ation model is characterised by an accelerated increase in the post-thymic age
of PTK7+ naive CD4+ T cells, or persistence of veteran cells, following thymec-
tomy, whereas, the homogeneity model is associated with a much slower in-
crease in the average post-thymic age of PTK7+ naive CD4+ T cells at a rate
that simply mirrors the natural aging of cells.
In reality, both natural inter-cellular variation and global changes to the rate
of PTK7+ T cell loss might play a role in the PTK7+ naive CD4+ T cell re-
sponse to thymectomy. An experimental approach that was able to measure
the post-thymic age of residual cells following thymectomy might allow us to
better determine the relative contribution of inter-cellular variation to T cell
homeostasis. In this work, the role of peripheral expansion of PTK7+ naive
CD4+ T cells is ignored, however, in appendix 4.5.2 the model is extended to
include a constant rate of division and the results are found to be robust to
background division within the PTK7+ pool. Furthermore, experimental stud-
ies measuring division within the PTK7+ naive CD4+ T cell population post-
thymectomy could quite easily allow the role of peripheral expansion to be
determined.4.4 Discussion 110
Do PTK7+ naive CD4+ T cells represent recent thymic emi-
grants?
Under the inter-cellular variation model, a heavy-tailed distribution of res-
idency times is best able to describe the post-thymectomy kinetics and the
change in PTK7+ naive CD4+ T cell numbers with age. An inherent conse-
quence of a heavy-tailed distribution is that, more-persistent, veteran PTK7+ T
cells will preferentially accumulate in an aging host resulting in a progressive
increase in the average post-thymic age of PTK7+ naive CD4+ T cells. Despite
the relatively short expected residency time of thymic emigrants within the
PTK7+ T cell population of  23 days, the accrual of a small persistent fraction
of cells from within each cohort of thymic emigrants over a number of decades
can lead to an average post-thymic age of PTK7+ naive CD4+ T cells of  10
years in a young adult. This suggests that although the PTK7+ naive CD4+ T
cell population contains recent emigrated T cells, not all PTK7+ cells are neces-
sarily recent emigrants. Although there are few experimental studies exploring
thelifespanofrecentthymicemigrants, ormorespeciﬁcallyPTK7+ naiveCD4+
T cells, this is consistent with the idea that the naive CD4+ T cell population in
older individuals is maintained by longer-lived cells [165–168]. Furthermore,
the accrual of persistent veteran T cells with age naturally explains the persis-
tence of a larger fraction of PTK7+ naive CD4+ T cells following thymectomy
in older individuals.
Thymectomy and premature aging of the T cell pool
Studies have suggest that the altered size of naive T cell subpopulations, for
example percentage of CD31+ naive T cells, in thymectomised individuals re-
semble observations in older subjects [113, 114]. However, it is shown here
under the variation model that even changes to the size of naive T cell subpop-
ulations may underestimate the true impact of thymectomy. Murine studies
have shown that naive CD4+ T cells derived from middle-aged thymectomised
mice are intrinsically longer-lived when adoptively transfered into younger
hosts, and more-closely resembled T cells from older donors, than T cells de-4.4 Discussion 111
rived from non-thymectomised mice [168]. Consistent with this observation,
the theoretical model presented here shows an accelerated increase in the av-
erage post-thymic age of residual PTK7+ naive CD4+ T cells, or equiavlently a
dominance of veteran cells, in a thymectomised individual that is more typical
of aged individuals. Furthermore, a recent vaccine study reported delayed IgG
production in response to tick-borne encephalitis virus vaccine in both thymec-
tomised children and elderly subjects [115].
The mechanisms that lead to age-associated changes in T cell behaviour are
not well understood. Adoptive transfer of young and aged bone marrow cells
into young and aged murine hosts indicate that both intrinsic changes in T cell
progenitors and defects in the aged environment in which cells develop are
partially responsible for the age-associated defects in function of recently em-
igrated T cells [169]. Furthermore, depletion of naive CD4+ T cells followed
by reconstitution by aged bone marrow seems to repair age-related dysfunc-
tion and newly produced T cells are found to be functionally similar to cells
from young mice [166, 169]. Together these observations suggest that aging
of the T cell population is driven by a complex product of extrinsic factors,
such as cytokine availability and size of the overall naive and memory com-
partments, and intrinsic factors, perhaps related to the changing expression of
co-stimulatory molecules, T cell receptors and other signalling proteins with
age.
A number of recent murine studies suggest that increased longevity of naive
CD4+ T cells facilitates the accumulation of functional defects [166,168,170]. If
we conjecture that the age of a cell is associated with function, then the increase
in average post-thymic age of cells as a result of the variation model described
here, suggests that inter-cellular variation might represent one more important
component of the aging process.4.4 Discussion 112
Does post-thymic positive selection shape the PTK7  naive
population?
Theoretically, there are a number of possible biological explanations for a
heavy-tailed distribution of PTK7 residency times, or equivalently a decline
in average rate at which cells transition from PTK7+ to PTK7  naive CD4+ T
cells with increasing time spent in the periphery. The intrinsic ability of cells to
transition into the PTK7  population may diminish with time if, for example,
necessary co-stimulatory or signalling molecules highly expressed at time of
exit from the thymus slowly dimish with time spent in the periphery. Alterna-
tively, variation in rate of transition from PTK7+ to PTK7  naive T cells might
reﬂect natural heterogeneity within each cohort of emigrants, where the resi-
dency time of a thymic emigrant in the PTK7+ state might be determined by
the strength of TCR afﬁnity, co-receptor density, or simply stochastic variation
in expression of signalling proteins.
AcorollarytothelattermodelisthattherecruitmentofperipheralPTK7+ naive
CD4+ T cells into the mature PTK7  naive T cell population involves an ele-
ment of post-thymic positive selection. The analysis presented here suggests
that despite a dramatic increase in the average post-thymic age of PTK7+ naive
CD4+ T cells in older individuals, the post-thymic age of cells entering the
PTK7  population is almost exclusively less than 3 months. If it assumed that
the residency time of a PTK7+ naive CD4+ T cell is linked to the ability of the
cell to respond to some maturation signals, then the ’shorter-lived’ PTK7+ cells
will represent the most responsive among all PTK7+ thymic emigrants. The
preferential incorporation of the more-responsive thymic emigrants into the
PTK7  naive CD4+ T cell population might explain why PTK7  naive CD4+ T
cells are more responsive to -TCR/CD3 and CD28 engagement than PTK7+
naive CD4+ T cells [3]. The differential responsiveness of resident naive T cells
and RTEs is also observed mice [87,171]. Further experimental studies explor-
ing the transition from PTK7+ to PTK7  naive CD4+ T cells will be important
not only for determining how well PTK7 expression correlates to recent thymic
emigration, but also for better understanding how new T cells are incorporated4.5 Appendices 113
in to the established naive T cell pool.
4.5 Appendices
4.5.1 Modeling division within the PTK7+ naive CD4+ T cell
population
The model of PTK7+ naive CD4+ T cell dynamics (equation 4.1) can be ex-
tended to allow for homeostatic division within the PTK7+ naive CD4+ T cell
population. We introduce a new variable, M(x), to represent the number of di-
vision events taking place within x days of a PTK7+ naive CD4+ T cell leaving
the thymus. The predicted size of the PTK7+ naive CD4+ T cell population at
any given time becomes a function of thymic export, the lifespan of cells and
the expected number of divisions:
X(t) =
Z t
0
(x)Fx(t   x)2
E[M(t x)]dx (4.12)
where E[M(x)] is the expected number of divisions occurring in x days of exit
from the thymus. In the absence of experimental data, we make the parsi-
monious assumption that the residency time of PTK7+ naive CD4+ T cell is
independent of homeostatic division events.
Using the same approach described in section 4.2, we compare equation 4.12 to
acorrespondingexpressionforthedecayofPTK7+ naiveCD4+ Tcellfollowing
thymectomy, allowing for division, to derive an expression for the residency
function of peripheral PTK7+ naive CD4+ T cells :
Ft0 (i) 
1
dX(t0)
dt 2qi
dX (i days post thymectomy)
dt
(4.13)
where, in the absence of experimental data we assume that the probability of
a PTK7+ naive CD4+ T cell dividing on any given day is constant, p and in-
dependent of time since export. Hence the expected number of divisions in i
days becomes qi.4.5 Appendices 114
Observing the change in PTK7+ naive CD4+ T cells following thymectomy
alone does not allow us to disentangle the effect of cell persistence and ex-
pansion. So we let the average rate of division within the PTK7+ naive CD4+
T cell pool (q) equal 0, 0.01, 0.10 and 0.50 (day 1). An arbitrary decay of PTK7+
T cells post-thymectomy is used to explore the impact of the different rates
of background division on the underlying rate of loss of PTK7+ naive CD4+
T cells (Figure 4.7). It can be shown that the per-cell rate of loss increases by
a constant amount, qLog[2], to compensate for a constant rate of division of q
(day 1) within the PTK7+ naive CD4+ T cell population.
Despite the unknown rate of division, the composite function of survival and
expansion of PTK7+ naive CD4+ T cells in equation 4.12, Fx(t   x)2E[M(t x)], is
identical to the survivorship computed in the simpler, no-division model. So
although the relative contribution of expansion and survival can not be quan-
tiﬁed, the net survivorship can be estimated and hence the observed shift in
post-thymic age of PTK7+ naive CD4+ T cells will be robust to a constant rate
of background division.
4.5.2 Estimating Post-thymic Age of the PTK7+ naive CD4+ T
cells
Using the predicted residency times of PTK7+ naive CD4+ T cells following
thymic export, Fx(t), the number of PTK7+ naive CD4+ T cells of a certain
post-thymic age, in an individual aged t, can be estimated as follows:
Nh(t) =
Z t
t h
(x)Fx(t   x)dx (4.14)
where (x) is the rate at which PTK7+ naive CD4+ T cells are exported by the
thymus and Nh(t) represents the number of PTK7+ naive CD4+ T cells in an
individual aged t exported within the past h days (h < t).4.5 Appendices 115
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Figure 4.7: Interpreting the decay of PTK7+ naive CD4+ T cells post-thymectomy
using a model of division within the PTK7+ naive CD4+ T cell population. Let
the rate of division (p) equal 0 (solid line), 0.01 (dotted line), 0.1 (short dashed
line) and 0.5 (large dashed line) (day 1) and explore the predicted residency times.
A: Arbitrary decline in PTK7+ naive CD4+ T cell numbers post-thymectomy in a
subject aged 14; B: Estimated survivorship function of PTK7+ naive CD4+ T cells
corresponding to PTK7+ T cell decay in A, where the rate of division (p) is set to
0 (solid line), 0.01 (dotted line), 0.1 (short dashed line) and 0.5 (large dashed line)
(day 1); C: Corresponding estimate for instantaneous per-cell rate of loss from the
PTK7+ naive CD4+ T cell population as a function of time since export.4.5 Appendices 116
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Figure 4.8: Using a lognormal distribution to describe the survivorship function
of PTK7+ naive CD4+ T cells A: Using the same approach as in Figure 4.3, a log-
normal PTK7+ T cell survivorship function is identiﬁed that best describes PTK7+
naive CD4+ T cell numbers in healthy individuals with age but is limited so that
it also lies within the the feasible range to describe post-thymectomy dynamics;
B: PTK7+ naive CD4+ T cell numbers observed in non-thymectomised, healthy
individuals (ﬁlled circles) by Haines & colleagues [3] compared to PTK7+ naive
CD4+ T cell numbers simulated using best-ﬁt lognormal survivorship function; C:
Predicted post-thymic age of the peripheral PTK7+ naive CD4+ T cells population
with age (absolute number of cells); D: Relative size of each post-thymic age cat-
egory; E: Average post-thymic age of peripheral PTK7+ naive CD4+ T cells as a
function of age.4.5 Appendices 117
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Figure 4.9: Modelling variation in residual thymic production. In this study the
implications of thymectomy are explored by assuming that 5% of thymic pro-
duction continues after thymectomy. Here we explore the robustness of the model
predictions by varying residual thymic production from 0 to 20%. A: Predicted de-
cline in total number of PTK7+ naive CD4+ T cells and corresponding post-thymic
age of cells; C & D: Average post-thymic age of residual PTK7+ naive CD4+ T cells
following thymectomy in a typical 2 year old where residual thymic production is
assumed to be 0% and 20%, respectively.Chapter 5
Conclusion
T cell homeostasis enables the immune system to maintain a stable naive T
cell population throughout adulthood. Better understanding of the natural ag-
ing process and the ability of the immune system to adapt to declining thymic
production provides further insight into situations where T cell homeostasis
is disturbed leading to T cell depletion, such as HIV infection and intentional
radiation- or drug-induced immuno-depletion.
Aging and T cell homeostasis
Aging is associated with an increase in infection, morbidity and decline in efﬁ-
cacy of vaccines [172]. The mechanisms that lead to age-associated changes in
T cell function are not well understood. The ability to maintain T cell numbers
and diversity with age is vital to the function of T cells in the adaptive immune
system. New speciﬁcities are added to the peripheral T cell repertoire through
the incorporation of newly formed lymphocytes from the thymus, while pe-
ripheral division has the ability to modulate the frequency of speciﬁc T cell
receptors. Knowledge of the relative contributions of thymic production and
peripheral expansion is important to better understanding the establishment of
the T cell repertoire. The aim of this thesis was to investigate the T cell kinetics
that regulate development, maintenance and subsequent aging of the naive T
cell compartment.
In this work, the relative contribution of thymic production and peripheral ex-119
pansion was shown to be approximately constant from birth to age 20 years.
The daily contribution of peripheral expansion to the naive T cell population
was found to be approximately 2 -fold greater than that of thymic output. This
is in accord with the hypothesis that thymic selection and export may not be
the primary force in shaping the T cell repertoire as previously thought.
Past studies of naive T cell dynamics assumed that rates of both proliferation
and loss are dependent on the size of the naive T cell population [53,126]. In
chapter 2, the average residency time of naive CD4+ T cells was shown to in-
crease with age suggesting that cells become longer-lived as the age of the host
increases, despite an increase in the absolute naive CD4+ T cell population. In
chapter 4, a model of natural inter-cellular variation in the residency times of
PTK7+ naive T cells was shown to be associated with an increase in the average
post-thymic age of PTK7+ naive CD4+ T cells in aging individuals. This model
might be extended in the future to the entire naive T cell population to provide
a possible mechanism for explaining the density-independent decline in rate of
loss of naive T cells with age. The model is characterised by an accumulation
of more-persistent T cells with age and might have serious consequences for
clonal diversity of T cells in an aging individual if residency time was linked to
TCR afﬁnity. The preferential accumulation of T cells associated with particular
TCR chains with age might contribute to the contraction of T cell population
diversity observed in elderly subjects [70].
In estimating the average rates of naive CD4+ T cell production and loss, it
was assumed that the population is homogeneous. It is known that the T cell
population can be divided into sub-populations of more, or less, recently em-
igrated cells, determined by expression of markers such as PTK7 and CD31,
where the relative size of each subpopulation changes with age. An extension
to this work could look more carefully at whether turnover occurs at the same
rate within different naive CD4+ T cell subpopulations.120
T cell depletion and T cell homeostasis
HIV infection is associated with a progressive depletion of CD4+ T cells. At
present there is no vaccine or cure for HIV but highly active anti-retroviral
therapy (HAART) is used to control the virus and delay the onset of acquired
immunodeﬁciency (AIDS). There were over 33 million people living with HIV
at the end of 2008, of which 2.1 million were children. Yet the nature of T cell
depletion associated with HIV and its underlying causes remain controversial.
The natural progression of HIV is typically characterised by a steep initial drop
in CD4+ T cell numbers during the ﬁrst few weeks of infection followed by an
asymptomatic chronic period during which CD4+ T cell counts decline gradu-
ally over a number of years. In addition, disease progression has been shown
to be closely associated with increased division and activation of both CD4+
and CD8+ naive and memory T cells [59,173–175]. The mechanisms by which
increased CD4+ T cell proliferation is associated with a decline in CD4+ T cell
numbers are not well understood and there exists signiﬁcant inter-patient vari-
ation in the rate of disease progression. In particular, studies have shown that
20-30% of vertically-infected infants will develop AIDS within the ﬁrst year of
life, while the average asymptomatic period in adults lasts 10 years [176,177].
It is not altogether surprising that there exists such differences between chil-
dren and adults since T cell depletion is driven by an imbalance between rates
of cell production and loss. The CD4+ T cell population in healthy adults is
known to be relatively stable, whereas the number, naive and memory compo-
nents, and thymic production of CD4+ T cells is known to change throughout
childhood.
A number of studies have suggested that thymic production and peripheral
proliferation of naive CD4+ T cells declines with age [1,2,8,52,70]. In this thesis,
it was shown that the predicted evolution of both thymic production and pe-
ripheral expansion can be divided into at least three distinct age-related stages:
(a) increase in T cell production from birth to age 1 year; (b) rapid decline un-
til  age 8 years; and (c) gradual decline into adulthood. The shift towards a
naturally less dynamics population with age is consistent with slower natural121
disease progression in adults since productive HIV infection predominantly
occurs in activated T cells. The increasing lifespan of naive T cells with age
may also play a role in HIV latency and the accumulation of virus in resting
cells.
Further work could quite feasibly use a similar mathematical approach to care-
fully re-evaluate the change in absolute naive CD4+ T cell numbers, TRECs
and Ki67 expression in HIV infection in individuals of different ages to quan-
tify thymic production. The impact of HIV and subsequent HAART on thymic
production remains unclear [2, 153] although it is important for our under-
standing of the consequences of HIV for repertoire diversity as well as T cell
counts. Interestingly, despiteadeclineintheconcentrationofcells, theabsolute
number of naive CD4+ T cells continues to increase with age in HIV- infected
children, although at a slower rate than that expected for uninfected children,
whereas adult infection is invariably linked to a decline in absolute CD4+ T
cell counts [2]. The observations highlight the fact that HIV disease progres-
sion is determined by subtle perturbation in the rate of cell production and loss
and mathematical models could play an important role in the future in better
understanding HIV progression and response to HAART.
Immune reconstitution and T cell homeostasis
Appreciating the capacity of the immune system to repopulate the T cell
population is important for predicting the outcome of HAART treatment as
well as stem cell and thymic transplants. Severe autoimmune diseases such
as systemic sclerosis, multiple sclerosis, sytemic lupus erythematosus (SLE)
and juvenile idiopathic arthritis are increasingly treated by immunoablative
chemotherapy followed by autologous hematopoietic stem cell transplantation
(ASCT) [178]. The aim of such treatments is to remove inﬂammation-driving
pathogenic cells from the immune system and reestablish immune tolerance.
It is thought that the de novo generation of naive T cells is able to reset the im-
munological clock, however, the exact mechanism through which ASCT ther-
apy works is not well understood. Long term analysis suggest that the fre-122
quency of naive T cells in individuals that have undergone reconstitution ex-
ceeds that of healthy individuals, while the frequency of memory T cells is
lower [179,180]. Earlier observations, at 6 months post-therapy, suggest that
the memory T cell compartment appears to initially outgrow the naive com-
partment [179,180] in line with T cell reconstitution observed in HIV-infected
adults undergoing HAART [136,181]. In contrast, reconstitution of the T cell
compartmentinHIVinfectedchildrenisdominatedbynaiveCD4+ Tcellsfrom
time of treatment initiation [182]. The kinetics of reconstitution appear to vary
with time since therapy initiation, age of host and T cell population size and
are not well deﬁned. It is thought that the initial period of reconstitution is
associated with extensive peripheral expansion of the T cell compartment, sug-
gesting that the relative contribution of thymic production and lymphoneia in-
duced proliferation may determine the relative reconstitution of the naive and
memory T cell compartments.
Declining thymic production with age is consistent with the limited reconsti-
tution of the naive compartment in adults and the predicted bi-phasic decline
in thymic production might suggest that there exists a threshold age beyond
which it is impossible to rebuild the entire naive T cell pool to normal values.
It would be interesting to explore the extent to which reconsititution mirrors
the original development of the T cell population during childhood.
The model of inter-cellular variation in residency times, described in chapter
4, leads to the accumulation of long-lived naive T cells in aging hosts and
might provide one explanation for the restorative effect and reconstruction of
a juvenile-like T cell population that follows ASCT. Furthermore, the ability
of adults undergoing ASCT, unlike HIV-infected adults undergoing HAART,
to successfully repopulate the naive T cell compartment might be evidence of
a reversion of thymic involution. Using a similar mathematical approach to
that described in chapter 3, the role of thymic rebound might be elucidated by
quantifying the contribution of de novo thymic production to the reconstituted
T cell pool.123
Thymectomy and T cell homeostasis
The thymus is commonly removed in children undergoing open heart surgery
and thymectomy was traditionally thought not to have clinical consequences in
infants as young as 6 months [107]. However, a number of recent studies sug-
gest that thymectomy may lead to premature immunosenescence of the T cell
pool [114,115]. In chapter 4, inter-cellular variation is shown to result in an ac-
celerated increase in post-thymic age of T cells following thymectomy. It is not
unreasonabletoassumethattheresidencytimeofaTcellmightberelatedtoits
functional properties. The model suggests that simply measuring T cell counts
may underestimate the consequences of thymectomy and that the procedure
may lead to a contraction of the T cell repertoire. More detailed experimental
observations in combination with mathematical analysis could allow the resi-
dency time of other naive (and memory) T cell subsets to be explored and may
provide a new window into the process of thymectomy.
Memory T cell homeostasis
In this thesis, the kinetic processes that guide the development of the naive T
cell compartment during childhood are quantiﬁed. A key aspect of naive T
cell dynamics is the loss of cells through differentiation into the memory T cell
compartment. In addition to foreign-antigen induced memory T cell creation, it
is thought that decreased competition for homeostatic signals in lymphopenic
conditions leads to increased proliferation and differentiation of naive T cells
into memory T cells [71]. The naive compartment is found to become progres-
sively less dynamic from birth to adulthood, suggesting that the rate at which
cells transition into the memory compartment might also declines with age.
A natural extension of this work would involve exploring the kinetics of the
memory CD4+ T cells, perhaps looking at the extent to which the acquisition
of new memory T cells related to the size of the memory and naive T cells com-
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